US20020119486A1 - Element and method for performing biological assays accurately, rapidly and simply - Google Patents
Element and method for performing biological assays accurately, rapidly and simply Download PDFInfo
- Publication number
- US20020119486A1 US20020119486A1 US10/091,296 US9129602A US2002119486A1 US 20020119486 A1 US20020119486 A1 US 20020119486A1 US 9129602 A US9129602 A US 9129602A US 2002119486 A1 US2002119486 A1 US 2002119486A1
- Authority
- US
- United States
- Prior art keywords
- reaction
- sample
- reaction volume
- cover
- light
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5023—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures with a sample being transported to, and subsequently stored in an absorbent for analysis
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F31/00—Mixers with shaking, oscillating, or vibrating mechanisms
- B01F31/30—Mixers with shaking, oscillating, or vibrating mechanisms comprising a receptacle to only a part of which the shaking, oscillating, or vibrating movement is imparted
- B01F31/31—Mixers with shaking, oscillating, or vibrating mechanisms comprising a receptacle to only a part of which the shaking, oscillating, or vibrating movement is imparted using receptacles with deformable parts, e.g. membranes, to which a motion is imparted
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F33/00—Other mixers; Mixing plants; Combinations of mixers
- B01F33/30—Micromixers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F35/00—Accessories for mixers; Auxiliary operations or auxiliary devices; Parts or details of general application
- B01F35/71—Feed mechanisms
- B01F35/717—Feed mechanisms characterised by the means for feeding the components to the mixer
- B01F35/7172—Feed mechanisms characterised by the means for feeding the components to the mixer using capillary forces
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
- B01L3/502715—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by interfacing components, e.g. fluidic, electrical, optical or mechanical interfaces
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
- B01L3/50273—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by the means or forces applied to move the fluids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/49—Blood
- G01N33/4905—Determining clotting time of blood
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
- G01N33/525—Multi-layer analytical elements
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F21/00—Dissolving
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F2101/00—Mixing characterised by the nature of the mixed materials or by the application field
- B01F2101/23—Mixing of laboratory samples e.g. in preparation of analysing or testing properties of materials
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F23/00—Mixing according to the phases to be mixed, e.g. dispersing or emulsifying
- B01F23/40—Mixing liquids with liquids; Emulsifying
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F23/00—Mixing according to the phases to be mixed, e.g. dispersing or emulsifying
- B01F23/50—Mixing liquids with solids
- B01F23/56—Mixing liquids with solids by introducing solids in liquids, e.g. dispersing or dissolving
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F31/00—Mixers with shaking, oscillating, or vibrating mechanisms
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/06—Auxiliary integrated devices, integrated components
- B01L2300/0627—Sensor or part of a sensor is integrated
- B01L2300/0654—Lenses; Optical fibres
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/06—Auxiliary integrated devices, integrated components
- B01L2300/069—Absorbents; Gels to retain a fluid
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0809—Geometry, shape and general structure rectangular shaped
- B01L2300/0825—Test strips
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0861—Configuration of multiple channels and/or chambers in a single devices
- B01L2300/0864—Configuration of multiple channels and/or chambers in a single devices comprising only one inlet and multiple receiving wells, e.g. for separation, splitting
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0861—Configuration of multiple channels and/or chambers in a single devices
- B01L2300/087—Multiple sequential chambers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0887—Laminated structure
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/18—Means for temperature control
- B01L2300/1805—Conductive heating, heat from thermostatted solids is conducted to receptacles, e.g. heating plates, blocks
- B01L2300/1827—Conductive heating, heat from thermostatted solids is conducted to receptacles, e.g. heating plates, blocks using resistive heater
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/18—Means for temperature control
- B01L2300/1861—Means for temperature control using radiation
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/04—Moving fluids with specific forces or mechanical means
- B01L2400/0403—Moving fluids with specific forces or mechanical means specific forces
- B01L2400/0406—Moving fluids with specific forces or mechanical means specific forces capillary forces
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/06—Valves, specific forms thereof
- B01L2400/0633—Valves, specific forms thereof with moving parts
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/06—Valves, specific forms thereof
- B01L2400/0633—Valves, specific forms thereof with moving parts
- B01L2400/0655—Valves, specific forms thereof with moving parts pinch valves
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/06—Valves, specific forms thereof
- B01L2400/0694—Valves, specific forms thereof vents used to stop and induce flow, backpressure valves
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
- B01L3/502738—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by integrated valves
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/01—Arrangements or apparatus for facilitating the optical investigation
- G01N21/03—Cuvette constructions
- G01N2021/0346—Capillary cells; Microcells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
- G01N2035/00346—Heating or cooling arrangements
- G01N2035/00435—Refrigerated reagent storage
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/47—Scattering, i.e. diffuse reflection
- G01N21/49—Scattering, i.e. diffuse reflection within a body or fluid
- G01N21/51—Scattering, i.e. diffuse reflection within a body or fluid inside a container, e.g. in an ampoule
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/645—Specially adapted constructive features of fluorimeters
- G01N21/648—Specially adapted constructive features of fluorimeters using evanescent coupling or surface plasmon coupling for the excitation of fluorescence
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
- G01N21/77—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator
- G01N21/78—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator producing a change of colour
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2201/00—Features of devices classified in G01N21/00
- G01N2201/06—Illumination; Optics
- G01N2201/066—Modifiable path; multiple paths in one sample
- G01N2201/0668—Multiple paths; optimisable path length
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
- G01N35/0098—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor involving analyte bound to insoluble magnetic carrier, e.g. using magnetic separation
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/805—Test papers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/81—Packaged device or kit
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/969—Multiple layering of reactants
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/97—Test strip or test slide
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/807—Apparatus included in process claim, e.g. physical support structures
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/807—Apparatus included in process claim, e.g. physical support structures
- Y10S436/81—Tube, bottle, or dipstick
Abstract
An element and method for easily performing liquid assays are disclosed. The element uses capillary action to draw a predetermined volume of a liquid sample into a reaction chamber charged with reagent, where reaction between the liquid sample and the reagent is monitored.
Description
- 1. Field of the Invention
- The present invention relates to disposable reagent-containing elements which can be used in conjunction with an electronic instrument for performing diagnostic assays (medical diagnostics). It also relates to a method for performing diagnostic biological assays employing the use of a disposable reagent-containing element.
- 2. Discussion of the Background
- Many analytical techniques have been developed for chemical, biochemical and biological assays. Procedures that use a discrete fluid sample for the analysis of a single analyte are traditionally characterized as wet chemical techniques or dry chemical techniques. In recent years both types of techniques have been automated to reduce costs and simplify procedures. Wet chemical methods, typified by the Technicon® autoanalyzers, utilize batches of reagent solutions, pumps and fluid controls, coupled with conventional sensors such as radiometric (e.g.: fluorescent, colorimetric, or nephelometric) electrochemical (e.g.: conductometric, polarographic, or potentiometric) and others, such as ultrasonic, etc. sensors. These techniques are characterized by large equipment, and are generally expensive. They are complicated, and require a skilled operator.
- Decentralized testing, particularly in medical applications, has been achieved with a variety of simpler systems often based on cuvettes for optical determination but sometimes based on dry chemistry-based “reagent strip” technology. Generally, a reagent strip is an absorbent structure containing a reagent which self-meters an applied sample and develops or changes color to indicate the extent of reaction. Although self metering, some reagent strips, however, require pipetting of sample to achieve maximum accuracy and precision. A reagent strip is employed either by itself or in conjunction with a simple instrument to read the color intensity or hue and translate the results into a numerical value which is displayed. Unlike a cuvette or test tube, mixing or convection cannot be sustained in a reagent strip after the sample has entered, and once having entered, the sample cannot be removed from within without destroying the integrity of the strip. In one application, reagent strip technology is used extensively in the home by diabetic patients who test themselves daily to determine blood sugar levels.
- In a more general example of “reagent strip” technology, Eastman Kodak has introduced a system of dry chemistry, claiming to overcome many of the traditional weaknesses of dry chemical methods. The Kodak technique utilizes flat, multi-layered sheets arranged in sequence. The top layer receives a liquid sample which passes downward undergoing separation and reactions in a pre-arranged sequence. The sheet is designed to accept a small volume of liquid and distribute it uniformly over a reproducible area. The area is less than the total area of the multi-laminar sheet. Each layer of the sheet is essentially homogenous in a direction parallel to the surface. Once the sample has spread radially (a rapid process), the components of the liquid can move downward at rates that are essentially the same in any plane that is parallel to the surface. In this way uniform reactions, filtrations, etc. can occur.
- The analyte is detected in the multi-layered sheets by radiometric or electrochemical methods which are carried out in a thermostated environment. This permits the use of kinetic and static measurements to detect analyte concentrations in a liquid sample.
- Radiation is caused to enter this assembly in a path which is traverse to the several layers. The radiation is modified by the analyte or by a component or product of the analyte. For example, the exciting radiation may be partially absorbed by the analyte or by a component or product of the analyte. The modified radiation may be reflected back transversely through the laminar assembly, typically from a reflective layer, adjacent or nearly adjacent to a thin layer where color is formed. Thus, reflectance can be monitored (as opposed to transmission only through the color producing layer). Reflectance, as expressed by Kubelka-Monk theory, consists of optical density absorbance and scattering components and is more sensitive than transverse colorimetry through a thin, turbid layer. Reflectance, however, may be a more difficult technique to standardize and to interpret data from than colorimetry.
- Conventional colorimetry has not been practiced with reagent strips because the color producing layers are generally thin and not transparent. The path of the exciting radiation is thus very short (with large light losses due to opacity) and is determined by the thickness of the layer in which the exciting radiation encounters the substance which is excited. Since this dimension must be very small to permit rapid measurement, e.g., 10 μm to 100 μm, the degree of modification of the exciting radiation is quite small. This limits the applicability of this technique to analyses in which the analyte (or the product of the analyte) interacts very strongly with the exciting radiation, otherwise a very sensitive detecting apparatus has to be used. This method has been shown to be useful for measuring analytes in blood that exist at relatively high concentrations, e.g., glucose, BUN, cholesterol and albumin.
- Other analytical methods have been developed that utilize rapidly reversable chemical reactions to continuously monitor analyte concentrations in biological fluids, or industrial effluent streams, or ponds, lakes and streams. For example, several methods have been proposed to measure the oxygen level in blood of critically ill patients.
- Reagent strip technology, however, possesses salient drawbacks and limitations. For example, once a sample is added to a reagent strip and permeates the porous structure of the strip, the sample cannot be removed or washed out without destroying the integrity of the strip. For example, immunoassays are extremely difficult to perform with reagent strips, in part because separation of free and bound antigen (or antibody) molecules from a mixture of both cannot be readily achieved in a conventional porous or layered structure. This limits possible immunoassay applications to certain special cases of reactions, for example certain homogenous reaction sequences. Incubation with mixing, a step common to a variety of assays, cannot be performed easily in conventional reagent strip formats since they rely on diffusion and initial capillary action only for mixing.
- Technologies have not yet been developed to cause or to control forced convection for a specified period of time within the porous structure of a reagent strip after the sample has entered and permeated the porous strip structure. In conventional reagent strips, the strip is an absorbant matrix in which mixing is extremely difficult and limited. In addition, reagent strips almost exclusively use reflectance as a photometric method to quantitatively determine the extent of a color reaction. There are no reagent strips known to the inventor which can be read via light transmission/absorbance colorimetry, nephelometry, fluorescence, chemiluminescence, or evanescent wave technology. Fluorescence measurement is possible in reagent strips, but difficult to achieve. Electrochemistry has been used successfully.
- As discussed above, a large number of types of medical tests are carried out by trained medical laboratory personnel. These tests must be performed accurately and reproducibly with a minimum amount of error since they are used as aids in diagnosing and treating medical ailments. To aid laboratory personnel in performing these tests accurately on a large number of samples in a relatively short period of time, auxiliary equipment, which is often expensive, is frequently used. Most of these tests are performed on a macro scale and thus require considerable quantities of both sample and reactants. They also require varying degrees of sample preparation. These and other reasons are major contributors to the generally relatively-expensive nature and inaccuracy of medical diagnostic tests performed on body fluids.
- Improvements have been made in some medical tests. For example, the reagent strip technology discussed previously simplifies medical tests, minimizes the required quantities of sample and/or reactants, can minimize possible sources of error, and lower costs. Various types of medical tests, however, have been difficult to perform accurately and economically on either a macro or a micro scale. In this respect, medical tests which require rapid and thorough mixing of reagents with a sample to provide a clearly defined starting point, an accurate measurement of reaction time, and a clear determination of the reaction endpoint, have been particularly difficult to perform with simple and inexpensive devices and have been plagued with inaccuracies resulting from errors in measurement and manipulation.
- Once such type of test is the blood prothrombin time test (“PT” hereinafter). This test measures the time required to form a blood clot (via extrinsic and common blood coagulation physiologic pathways).
- Coagulation assays, in general, are used for a variety of reasons. They are principally used for monitoring patients receiving anticoagulant therapy. The most frequently performed coagulation assay is PT. Prothrombin time determinations are used to monitor patients receiving oral anticoagulants such as warfarin. An accurate monitoring of coagulation in these patients is important to prevent recurrent clotting (thrombosis) and to keep the coagulation mechanism sufficiently active to prevent internal bleeding. Prothrombin time testing provides information to permit better drug control to be achieved through the regulation of drug dosage.
- In conventional practice, PT assays are performed by the addition of a liquid reagent to a plasma sample. The reagents are typically supplied in dried form and consist primarily of thromboplastin and calcium chloride. The dried reagent is reconstituted before use by addition of a measured amount of distilled water. The reagent is thermally sensitive, and refrigeration prior to use is required. The shelf life of the reagent in dried form is from one to two years. However, when it is reconstituted the reagent is considerably more labile and must be used within a few hours or discarded. In some cases reconsistuted reagents can be kept for a few days under refrigeration.
- Prothrombin time assays are performed by mixing sample and reagent at 37° C., and monitoring the progress of the reaction until a perceptible clot (or “gel clot”) is detected. The development of a gel clot is the end point of the reaction. This end point may be detected in various ways; by viscosity change, by electrode reaction; and, most commonly, by photometric means. The test result is generally compared to a result using a normal (control) plasma.
- Before performing the test, the blood sample is collected in the tube or syringe containing anticoagulant (citrate). The blood sample is centrifuged, and the plasma separated (e.g., by decantation) from the red blood cells. A measured quantity (usually 0.1 ml) of plasma is pipetted into the reaction vessel or cuvet. A measured amount of reagent is then added manually via pipette or automatically by means of other volumetric delivery systems capable of metering a known, preset quantity of reagent. Alternatively, the sample can be added to the reagent directly. Typically, 0.2 ml of reagent is employed. The addition of the reagent initiates the reaction.
- Some PT kits for use in the home are known. For example, McCormick (U.S. Pat. No. 3,233,975) discloses a prothrombin reaction chamber. The chamber is constructed of a transparent material so that the progress of the reaction can be visually monitored. To perform a blood prothrombin time test with this chamber, one adds sequentially a measured volume of a prepared blood sample and a measured volume of an aqueous solution of reagent to the chamber. The chamber is then manually agitated, and the progress of the reaction visually monitored and timed with a stop watch.
- This prothrombin reaction chamber, however, suffers from numerous disadvantages. For the prothrombin test to be performed with this reaction chamber, a prepared blood sample is used. Thus sample manipulation is required. A specific volume of the prepared blood sample must be added to the chamber. The measurements involved in obtaining this specific volume of prepared blood sample contribute inaccurate results and considerable labor.
- This reaction chamber also requires the preparation of a solution containing the reagent(s). The precise measurement of the amounts of materials and water to be combined in preparing the reagent solution introduces another additional source of error. The measurement of the quantity of reagent solution to be added to the chamber provides a further source of error. Moreover, as discussed above, having to use a reagent solution is undesirable because of potential stability problems. If the reagent solution is not used within a few hours, the solution must be discarded.
- McCormick's prothrombin reaction chamber is based on the visual observation of the reaction to measure clotting time. It does not permit accurate monitoring of sample mixing with the reagent(s), accurate determination of reaction starting point (which is as important as the end point when reaction time is being measured), or accurate determination of reaction end point.
- Accordingly there is a strongly felt need for a facile and accurate method for the performance of biological assays, e.g., in medical application. Such method should be based on a minimum number of manipulations of either a sample or reagent.
- Ideally it should require no sample or reagent-containing solution preparation. It should minimize problems associated with reagent instability and optimize accuracy. It should permit effective mixing of sample and reagent. It should permit sample manipulation. It should require only a very small amount of sample. And it should be able to perform automatic treatments of the sample, e.g., separate red blood cells from plasma in blood. This method should be based on a simple and inexpensive reagent-containing element.
- Accordingly, it is an object of this invention to provide a facile method for the performance of assays, e.g., biological assays.
- It is another object of this invention to provide a facile and accurate method for the performance of assays, e.g., biological assays.
- It is another object of this invention to provide a method for the performance of assay where the method is based on a minimum number of manipulations of either sample or reagent.
- It is another object of this invention to provide a method for the performance of assays requiring no preparation of sample or reagent-containing solution.
- It is another object of this invention to provide a method for the performance of assays which minimizes problems associated with reagent instability.
- It is another object of this invention to provide a method for the performance of assays in which accuracy is optimized.
- It is another object of this invention to provide a method for the performance of assays permitting an effective mixing of sample and reagent(s).
- It is another object of this invention to provide a method for the performance of assays permitting sample manipulation.
- It is another object of this invention to provide a method for the performance of assays requiring only a very small amount of sample.
- It is another object of this invention to provide a method for the performance of assays permitting the automatic treatment of the sample, e.g., separation of the red blood cells from plasma and blood.
- It is an object of this invention to provide a novel element which permits the facile and accurate performance of diagnostic assays.
- It is another object of this invention to provide such an element which can be used in diagnostic assays without requiring the preparation of a reagent solution from dry reagent.
- It is another object of this invention to provide such an element permitting the accurate testing of samples with minimum sample manipulation.
- It is another object of this invention to provide a novel element for performing a diagnostic assay in which no measurement of sample or reagent is required for performance of the assay.
- It is another object of this invention to provide a novel element for performing a diagnostic assay permitting an optimization of accuracy.
- It is another object of this invention to provide a novel element for performing a diagnostic assay permitting the effective mixing of sample and reagent(s).
- It is another object of this invention to provide a novel element for performing a diagnostic assay permitting sample manipulation.
- It is another object of this invention to provide a novel element for performing a diagnostic assay requiring only a very small amount of sample.
- It is another object of this invention to provide a novel element for performing a diagnostic assay capable of automatically treating the sample, e.g., separating red blood cells from plasma and blood.
- Surprisingly, all of these objects, and other objects which will become obvious from a description of the invention provided hereinafter, have all been satisfied with the discovery of the present reagent-containing element for performing diagnostic biological assays. This element comprises a channel structure defining a sample well and a reaction volume in communication with each other. The channel structure possesses a geometry which causes a liquid sample placed into the sample well to be drawn into and filling the reaction volume via capillary action, wherein after the reaction volume is filled, the liquid sample remains stationary.
- In the assembly of this element, the element can comprise a base, an overlay, and a cover. The base comprises a major surface. The overlay is situated on the base. The cover is situated on the overlay, opposite the base. The overlay comprises a channel structure defining a sample well and a reaction space in communication with each other. The cover comprises a means for adding a sample to be analyzed to the sample well.
- The assay is performed by monitoring a reaction of the sample in the reaction space with the sample as a whole being stationary during essentially all of the assay. After the assay, or to permit manipulation of the sample, the sample can be removed from the reaction volume, but the geometry of the present element provides for the immobility of the sample once the reaction volume has been filed.
- Although the element can comprise the base, overlay and cover assembly described above, it can be produced by using any material forming technique which will produce the desired geometry. Thus, instead of assembling the base, overlay and cover as separate components, the element can be produced by assembling either fewer or a greater number of components. For example, the element can be produced by injection molding whereby one obtains two pieces which when assembled produce the element of this invention.
- In certain embodiments, the element also comprises a means for channelling light from an outside source to the reaction chamber. This means is referred to as a waveguide in this text. Such an element is used with a means for detecting light emitted from the reaction chamber. Other embodiments measure non-optical properties of the sample. Such measurements may, for example, be conductometric, polarographic or potentiometric in nature, or may involve a combination of the above.
- Of course, the present invention also provides a novel method for performing a diagnostic assay. This method is based on using the reagent-containing element of this invention. The assays which can be performed are all liquid system assays, i.e., assays using a liquid media. A specific example of such assays is biological assays.
- An element containing a measured amount of at least one reagent situated in the reaction space of the element, is used. A biological sample is added to the sample well of the reagent-containing element. The geometry of the reagent-containing element forces a specific volume of the biological sample to be drawn from the sample well by capillary action to the reaction space. In the simplest case of reagent containment, once the sample enters the reaction space it contacts the reagent, dissolving the reagent. Using the means for channelling light from an outside source to the reaction chamber, light is impinged upon the reaction space during the whole process. Light emitted from the reaction space is monitored, permitting monitoring of the dissolution process, the progress of the reaction, the end of the reaction, and a determination of reaction time.
- A more complete appreciation of the invention and many of the attendant advantages thereof will be readily obtained as the same becomes better understood by reference to the following detailed description when considered in connection with the accompanying drawings, wherein like reference numerals designate identical or corresponding parts throughout the several views.
- FIG. 1 is a top view of a cover of a first embodiment of a reaction slide according to the current invention.
- FIG. 2 is a top view of an overlay of a reaction slide according to the first embodiment.
- FIG. 3 is a top view of a base of a reaction slide according to the first embodiment.
- FIG. 4 is an exploded perspective of the items shown in FIGS.1-3, the elements being oriented as in the assembled reaction slide.
- FIG. 5 is a top view of the elements of FIGS.1-3, when assembled.
- FIG. 6 is an elevational longitudinal cross-section of a first embodiment of a reaction slide according to the current invention, the cover, overlay and base being sectioned along line VI-VI of FIG. 5.
- FIG. 7 is an elevational cross-section of a fragment of a reaction slide according to the current invention, illustrating a modification in which the reaction slide comprises a spacer that includes two overlays.
- FIG. 8 is a top view of a second embodiment of a reaction slide according to the current invention.
- FIG. 9 is a top view of a cover of a third embodiment of a reaction slide according to the current invention.
- FIG. 10 is a top view of an overlay of the third embodiment.
- FIG. 11 is a top view of the base of the third embodiment.
- FIG. 12 is a top view of the third embodiment.
- FIG. 13 is an elevational cross-section taken along line XIII-XIII of FIG. 12, further showing a liquid absorbing matrix.
- FIG. 14 is a top view of a fourth embodiment of a reaction slide according to the current invention.
- FIG. 15 is an exploded view of a fifth embodiment of a reaction slide according to the current invention.
- FIG. 16 is a top view of the fifth embodiment.
- FIGS. 17 and 18, respectively, are elevational cross-sections taken on lines XVII-XVII and XVIII-XVIII of FIG. 16.
- FIG. 19 shows a transverse cross-sectional elevation of a reaction slide, a preferred embodiment of a light source, also in section, and a light detector, the light source and light detector being disposed for making a reflectance measurement.
- FIG. 20 is a top view of a reaction slide disposed in a housing for making a reflectance measurement, a cover of the housing being removed.
- FIG. 21 is an elevational cross-section taken on line XXI-XXI of FIG. 20, also showing the cover of the housing.
- FIG. 22 is an exemplary graph showing typical results of a measurement of prothrombin time.
- FIG. 23 schematically illustrates apparatus for measuring prothrombin time.
- FIG. 24 schematically illustrates a vertical cross-section of a modification of a reaction slide that does not employ adhesive layers, the figure illustrating light entering that embodiment.
- FIG. 25 illustrates the use of a reaction slide (unsectioned), external waveguides and apparatus for making a transmission/absorbance measurement.
- FIG. 26 is a view similar to that of FIG. 25, illustrating simultaneous measurements of light scattering and transmission/absorbance.
- FIG. 27 illustrates a reaction slide and a light detector, disposed for making a measurement based upon chemiluminescence.
- FIG. 28 shows a reaction slide disposed above a partial integrating sphere for making a measurement based on reflectance.
- FIG. 29 illustrates simultaneous measurements based on light scattering and transmission/absorbance through the reaction space and the use of the cover in making a fluorescent evanescent wave measurement.
- FIG. 30 illustrates the use of the base of a reaction slide in making a fluorescent evanescent wave measurement.
- FIG. 31 illustrates the use of a screen for setting up convective currents in the reaction space.
- FIG. 32 illustrates the use of a permanent magnet for setting up convective currents in the reaction space.
- FIG. 33 illustrates the use of a solenoid for setting up convective currents within the reaction space.
- FIG. 34 illustrates apparatus for producing localized deflection of the cover to produce convective currents within the reaction space.
- FIG. 35 is a transverse elevational cross-section of a reaction slide provided with a colorimetric transducer.
- FIG. 36 is a top view of a reaction slide, with the cover removed, the reaction slide being provided with an electrochemical transducer.
- FIG. 37 is a transverse cross-sectional elevation of a reaction slide provided with a viscosity transducer.
- FIG. 38 is a longitudinal cross-sectional elevation of a reaction slide augmented for performing a continuous flow measurement and having a reagent-containing layer disposed on the base.
- FIG. 39 is a fragment of FIG. 38 in the area of the reaction space, in which the reagent-containing layer is in the form of a reagent-containing gel.
- FIG. 40 is a fragment of FIG. 38 in the area of the reaction space in which the reagent-containing layer is in the form of a reagent-containing membrane disposed above a liquid absorbing matrix.
- FIG. 41 is a fragment of FIG. 38, modified by the addition of a recess in the base to accomodate a liquid absorbing matrix and a second reagent-containing layer.
- FIG. 42 illustrates a reaction slide modified for use in initiating an assay.
- FIGS.43-51 are longitudinal cross-sectional elevations of a reaction slide during various stages of an ELISA type immunoassay.
- FIGS.52-60 schematically illustrate the physiochemical conditions within the reaction space during each of the stages illustrated in FIGS. 43-51.
- FIG. 61 is a longitudinal cross-sectional elevation of a reaction slide in which a reagent-containing matrix fills a substantial portion of the reaction space.
- FIG. 62 is a top view, with the cover partially removed, of independent reaction spaces disposed on a common base.
- FIG. 63 is a top view of a reaction slide of the parallel flow type having three reaction spaces.
- FIG. 64 is a top view of a reaction slide of the serial flow type having three reaction spaces.
- FIG. 65 is a top view of a reaction slide of the parallel flow type having two reaction spaces, also showing light sources and detectors.
- FIG. 66 is a transverse elevational cross-section taken on line LXVI-LXVI of FIG. 65. Together, FIGS. 65 and 66 illustrate apparatus that may be used in conducting a Plasminogen Activator assay.
- FIG. 67 is a longitudinal cross-sectional elevation of a reaction slide having a vent cover useful in selective venting.
- FIG. 68 is a top view of a reaction slide provided with a pinch valve.
- FIG. 69 is a section taken on line LXIX-LXIX of FIG. 68, also showing a push rod for actuating the pinch valve.
- FIG. 70 is a top view of a reaction slide having an auxiliary conduit.
- FIG. 71 is a schematic representation illustrating how two liquids may be selectively introduced into a common chamber.
- FIGS.72-74 schematically illustrate various forms of cascading.
- FIG. 75 is a longitudinal vertical cross-section of a reaction slide together with apparatus for using suspended magnetic particles to measure a coagulation reaction.
- Shown in FIG. 1 is a top view of a
cover 10 of a first embodiment of a reaction slide according to the current invention. Shown in FIG. 2 is a top view of anoverlay 20 of the first embodiment. Shown in FIG. 3 is a top view of abase 30 of the first embodiment. - FIG. 4 is an exploded view showing the relative positions of the
cover 10,overlay 20 andbase 30. - FIG. 5 is a top view of the
cover 10,overlay 20 andbase 30, when assembled. - FIG. 6 is a longitudinal vertical cross-section of a first embodiment of a
reaction slide 1 according to the current invention. Thecover 10,overlay 20 andbase 30 are sectioned along line VI-VI of FIG. 5. As will be described more fully below, thereaction slide 1 contains certain elements in addition to those shown in FIGS. 1-5. - Now referring generally to FIGS.1-6, the
cover 10 comprises a thin glass or polymeric sheet, typically transparent, having formed therein asample receiving opening 14 and anelongate opening 12 proximate adistal end 16 of the cover. - The
overlay 20 comprises a thin glass or polymeric sheet, typically transparent, having formed therein a cut-out, the cut-out having a geometry as shown to form asample receiving opening 22, areaction space 24 and aconduit 26 communicating the reaction space and the sample receiving opening. (Thereaction space 24 becomes a reaction volume upon assembly of the cover, overlay and base.) Advantageously, taperingwalls 25 form a transition between theconduit 26 andreaction space 24. Thedistal end 28 of the overlay is closed as shown at 29. - The
base 30 comprises a sheet of glass or polymeric material, typically transparent and typically somewhat thicker than either thecover 10 oroverlay 20. - The
cover 10 andbase 30 are separated by a spacer 60 (FIG. 6), thespacer 60 being made up of theoverlay 20 sandwiched between twoadhesive layers 62 which respectively join theoverlay 20 to thecover 10 and theoverlay 20 to thebase 30. Each of theadhesive layers 62 has the same shape as theoverlay 20. That is, each of the adhesive layers is formed with an opening having a shape corresponding to thesample receiving opening 22, thereaction space 24 and theconduit 26 of theoverlay 20. Accordingly, there are formed in the reaction slide a sample well 64, areaction volume 66, a conduit communicating thereaction volume 66 and the sample well 64, and avent 76 formed by theopening 12 in thecover 10 communicating thereaction volume 66 with the environment of the slide. - The bottom surface of the
cover 10, facing thebase 30, is spaced from the top surface of the base 30 by a distance that is sufficiently small to cause a sample placed in sample well 64 to be drawn into thereaction volume 66 by capillary action. Such action is made possible by the presence of thevent 76. - As shown in FIG. 5, the length (left to right in the drawing) of the
cover 10 is the same as that of theoverlay 20, and the width (top to bottom in the drawing) of thecover 10 andoverlay 20 are the same and are less than that of thebase 30. - Preferably there is provided a liquid absorbing matrix (LAM) for withdrawing fluid from the reaction space when desired. To this end, there may be provided as shown in FIG. 6 a
LAM assembly 50 including aLAM pad 51, illustrated as a sponge, fixed on aLAM support 52, theLAM support 52 comprising anarm 53, atab 54 fixed on thebase 30, and aliving hinge 55 joining thearm 53 andtab 54. When thearm 53 is pressed downwardly, manually or by an automated presser (not shown), theLAM 51 will enter thevent 12 and make contact with fluid in thereaction volume 66, thereby drawing out the fluid. It has been found that, when thecover 10 is made of a polymeric material, this withdrawing action may be enhanced by downward deflection of a portion of thecover 10 adjacent thevent 12. It would appear that this enhanced withdrawal is caused by a localized narrowing of the distance between thecover 10 andbase 30, thereby creating a narrowed passage to enhance capillary action. Thus although thecover 10 can be made of either rigid of flexible material, in this embodiment or the invention, thecover 10 is preferrably made of a flexible material. - Observations and measurements of chemical reaction occurring within the
reaction volume 66 may be made by a number of methods, as described more fully below. At present, optical methods are preferred, but the choice of method will depend upon the assay being performed. Shown in FIG. 4 are a number of paths that light may typically follow for making such measurements and observations. These paths may be used alone or in combination. - In
light path 40, light is introduced through a side of theoverlay 20 and passes initially through a portion of the overlay disposed between theclosed end 29 and taperingwall 25. This portion of the overlay and its opposite corresponding portion will be referred to asinternal waveguides 27. Thereafter, the light passes through thereaction volume 66 and out through theopposite waveguide 27. As illustrated schematically, light passing in this direction through the waveguides is internally reflected off the top and bottom surfaces of theoverlay 20.Light path 40 is useful in making measurements based on the transmission or absorbance of light by the fluid within thereaction volume 66, in which case there is measured the ratio of light intensity before and after passing through the sample in the absence of scattering or excluding scattering. The Beer-Lambert Law describes the phenomenon. Standard detectors are employed in a line of sight configuration with the light source. -
Light path 41 illustrates a measurement that may be made based upon light scattering in which light is first introduced transversly through aninternal waveguide 27, enters thereaction volume 66, is then scattered by the sample, a portion of the scattered light proceeding downwardly through thebase 30 and then leaving the reaction slide. Light scattering measurements or nephelometry measures light which is not irreversibly absorbed by the sample and emerges at various angles, the spatial/intensity distribution being dependent upon particle size, shape and wavelength of the excitation energy. Rayleigh and Mie theories are useful models. Standard detectors are employed. Examples are photocells or photomultipliers, the latter being employed at very low light levels. Excitation source wavelength may be fixed at a particular value. The detector is typically set at a predetermined angle from the direction of excitation. -
Light paths cover 10 andbase 30, experiencing total internal reflection as it passes directly above and beneath the reaction volume, respectively, and exiting through the opposite edge of the cover or base. As will be explained more fully below, such light paths may be employed for detecting fluorescence using an evanescent wave measurement. - Other light paths are possible, including vertical paths passing through the cover, reaction volume and base and light paths making use of reflectance off a sample in the reaction volume, according to which light may both enter and leave the reaction volume by way of the
cover 10 orbase 30. - It will typically be desirable to exclude stray light from entering the reaction slide. For this purpose, any external surface of the reaction slide which is not to be used for the transmission of light may desirably be painted with an opaque paint. The choice of surfaces to be so painted will be governed by the assay to be performed and the elected methods of measurement. When any of the
components - When using light-paths such as40 and 41 in FIG. 4, it becomes important to transmit as much light as possible through one or both of the
internal waveguides 27, keeping the losses as low as possible. It has been found that the presence of theadhesive layers 62 can cause thespacer 60 to perform like an optical fiber, thewaveguides 27 corresponding to a core of an optical fiber and theadhesive layers 62 corresponding to cladding. - Refractive index mismatch between the
waveguide 27 and theadhesive layers 62 produces total internal reflection of light striking the interface at angles greater than the critical angle. By way of example, reference is made to FIG. 24, wherein there are showncore 70, cladding 71 surrounding thecore 70, and incidentlight ray 72 striking and passing through thecore 70. The core 70 may correspond to theinternal waveguide 27 of the overlay, and thecladding 71 may correspond to the adhesive layers 62. If, for example, thecore material 70 has a refractive index n1 of 1.62 and thecladding 71 has a refractive index n2 of 1.52, the sine of the critical angle is n2/n1, or 1.521/1.62=0.938. The critical angle is then 69.8 degrees. - Referring now to FIG. 7, there is shown a fragmentary vertical cross-section of a modification of the embodiment of FIGS.1-6, the view of FIG. 7 being taken at a representative location corresponding, for example, to the extreme left-hand portion of FIG. 6. In this modification, the
spacer 60 includes a second overlay 68 which is substantially identical to theoverlay 20. A thirdadhesive layer 62 is used to join theoverlay 20 and the second overlay 68. Because the second overlay 68 is identical to thefirst overlay 20, it forms a second pair ofinternal waveguides 27. The additional cross-sectional area provided by theadditional waveguides 27 substantially increases the amount of light that may be introduced into thereaction volume 66 through theinternal waveguides 27. - Referring now to FIG. 8, there is shown a top view of a second embodiment of a
reaction slide 1 according to the current invention. Thebase 30 andoverlay 20 of this embodiment are identical to those shown in the embodiment of FIGS. 1-6. However, thecover 10 has a length that is less than the length of theoverlay 20. There is provided anend cover 75, coplanar with thecover 10 and spaced therefrom to form a gap. This gap createsvent 76, communicating thereaction volume 66 with the environment of thereaction slide 1. For the sake of clarity, theLAM assembly 50 is not shown. - Additional variations of the above-described embodiments are possible. For example, it is not necessary for a LAM assembly to be fixed on the
base 30. Such an assembly may be provided separately and may be manipulated manually or using an automated system. - The adhesive layers62 may be omitted, and an alternative method such as heat sealing may be used to join the
cover 10,overlay 20 andbase 30. In such a case, thespacer 60 is formed entirely by theoverlay 20. Referring again to FIG. 24, in such a case theinternal waveguide 27 of theoverlay 20 will again act as acore 70 of an optical fiber, but thecladding 71 will be formed by thecover 10 andbase 30. - FIGS.9-11 show top views of, respectively, a
cover 10,overlay 20 andbase 30 of a third embodiment of a reaction slide according to the current invention. FIG. 12 shows a top view of the assembled reaction slide of this embodiment. This embodiment differs from that of FIGS. 1-6 in the omission ofconduit 26 and in that thedistal end 28 of theoverlay 20 is open, so that the reaction space vents longitudinally between thecover 10 andbase 30 instead of vertically through the cover. - The
cover 10,overlay 20 andbase 30 may be secured to each other usingadhesive layers 62 as described in connection with the previous embodiments, or theadhesive layers 62 may be omitted and the various elements of the reaction slide may be joined by heat sealing or solvent bonding, etc. . . . It has been found that, where heat sealing is employed, discontinuities in the heat seal often result, impairing the total internal reflection of light when passing through thewaveguides 27. To compensate for such impairment, areflective layer 78 may be placed atop thewaveguide 27 of theoverlay 20 through which light will be introduced. A correspondingreflective layer 80 may be placed on thebase 30. Such reflecting layers also may be used in other embodiments according to the current invention, if desired. - FIG. 13 illustrates the open-ended reaction volume of the embodiment of FIGS.9-12, together with the addition of a
LAM 82 in a configuration preferred for use with such an open-ended reaction volume. In particular, theLAM 82 is fixed on thebase 30 and overhangs thedistal end 16 of thecover 10. When it is desired to remove liquid from thereaction volume 66, theLAM 82 is depressed, resulting in a localized deformation ofcover 10 andLAM 82, causing contact between theLAM 82 and the fluid in thereaction volume 66 for the withdrawal of the fluid. - Shown in FIG. 14 is a top view of a fourth embodiment of a
reaction slide 1 according to the current invention. In this embodiment, thedistal end 28 of the overlay is open, as is the case with the embodiment of FIGS. 9-13, such that thereaction volume 66 vents between thecover 10 andbase 30. Thecover 10 is shorter than theoverlay 20, so that a portion of theoverlay 20 may be seen extending to the right in the drawing from beneath the cover. Theoverlay 20 is provided with afirst conduit 90 communicating the sample well 64 with thereaction volume 66 and asecond conduit 92 extending backward to a point beyond the sample well, such that theend portion 94 ofconduit 92 extends beyond the edge of the cover. Thesecond conduit 92 and itsend portion 94 are used for visual inspection to determine that proper filling has been achieved. - In particular, in a typical use of a reaction slide according to the current invention, that portion of the reaction slide containing the
reaction volume 66 will be disposed within a measuring instrument, whereas that portion of the reaction slide containing the sample well will extend out of the measuring instrument so that a sample may be introduced into the sample well 64 when desired. When the sample passes from the sample well 64 into thereaction volume 66, it no longer is visible to the user, that portion of the reaction slide being disposed within the measuring instrument. Accordingly, when the user observes the presence of sample inend portion 94 ofsecond conduit 92, it is assured that proper filling has been achieved. It may be seen that a reaction slide according to this embodiment is most useful in those cases when thecover 10 is opaque. In the alternative, if the cover is transparent, substantially all of thesecond conduit 92 may be used for visual observation of proper filling. In such a case, it is not necessary that thesecond conduit 92 extend beyond the end ofcover 10 as illustrated, and the length of thecover 10 may be the same as the length of theoverlay 20. -
Second conduit 92 is not essential, as proper filling may be monitored by electro-optic means using the same light detectors used in monitoring the results of the assay being performed. Indeed, the embodiments of FIGS. 1-13 do not employ asecond conduit 92. - FIG. 15 is an exploded view of a fifth embodiment of a
reaction slide 1 according to the current invention. A top view of this embodiment is shown in FIG. 16, with selected vertical transverse cross-sections being shown in FIGS. 17 and 18. - There is shown a
base 30 on which is fixed aninsert 110 and insertcover 100.Insert cover 100 is generally formed by a majorplanar segment 101 having lateral sides bent downwardly outward to formwalls 104 and then laterally to formtabs 106. Thetabs 106 are bonded to the base 30 with theinsert 110 being disposed between theplanar segment 101 of theinsert cover 100 and thebase 30, the height of thewalls 104 generally corresponding to the height of theinsert 110. -
Insert 110 includes asample receiving opening 112 communicating with aconduit 114 which ends in outwardly taperingwalls 116. As the length of theinsert 110 is substantially less than the length of theinsert cover 100, areaction volume 66 is formed to the right of the insert as shown in FIG. 16. - Thus, it may be seen that the
walls 104 in the area of thereaction volume 66 serve the functions of the internal waveguides of the previous embodiments, and for this purpose at least those portions of thewalls 104 that are disposed in the vicinity of thereaction volume 66 are made of a transparent material. - Although the
insert 110 may be bonded to thebase 30, variations are possible. For example, the insert and base may be formed as one piece, molded or machined to the appropriate shape and channel structure. - As will be described in more detail below, an assembled reaction slide according to the various embodiments will typically contain one or more reagents specifically selected for their utility in performing any of the many assays that may be performed using reaction slides according to the current invention. For example, liquid reagent may be placed in the reaction volume by filling through the sample well or, preferably, through the vent. The reagent can then be freeze-dried, the exact conditions of the freeze-drying process being dependent upon required optima and the type of reagent employed. There is thus produced a reaction slide, ready for use, having a premeasured amount of reagent disposed therein.
- Typically, it may be desired to modify the internal surfaces of the reaction slide which will contact the sample or reagent or both to modify the liquid/solid/air contact angle of the surfaces, the surfaces thus being treated to increase their hydrophilic character. Such treatment will increase the ease with which the sample flows from the sample well to the reaction volume.
- There are a variety of methods available for decreasing contact angle on a hydrophobic (or nonpolar) surface, thereby rendering it more hydrophilic. Surface active agents (or surfactants) which are typically employed as wetting agents may be used. For example, small amounts of Triton type dispersion agents, Tween (polyoxyethylene derivatives of fatty acid partial esters of hexitol anhydrides) type surface active agents, and Brij (polyoxyethylene ethers of higher aliphatic alcohols) type wetting agents may be utilized. Surface modification via chemical derivitization of surface molecules can create polar prosthetic groups. Other techniques include surface modification using controlled electrical discharge or plasma treatment.
- It should be noted that the height of the reaction volume is critical and is defined by the thickness of the
spacer 60. This height should be uniform and can range from 0.001 to 0.02 inches (approximately). Typically, this height is preferably from 0.002 inches to 0.008 inches, and most preferably approximately 0.006 inches. - This order of magnitude is not only appropriate to achieve functional capillary action in the channels but is of the same order of magnitude as is required, generally, for optical waveguide transmission of light by total internal reflection. Coincidentally, this dimension is approximately of the order of magnitude required to produce preferential phase separation to the center of a flowing stream of suspended particulate or cellular material in a two phase system (or suspension) during sustained laminar flow conditions which may be achieved, as will be described below.
- For construction of the reaction slide, all materials which come in contact with sample or reagent should be relatively inert. The surface properties of the materials should be such that appropriate wetting of the surface is achieved by the sample to provide proper flow conditions. Generally a low contact angle is best.
-
Cover 10 may be fabricated from a solid thin sheet of paramagnetic material or a laminate consisting of a coated paramagnetic material or could be fabricated from plastic or glass. - The paramagnetic material could be iron or nickel. Chemically inert thin coatings, such as polyvinyl chloride, acrylic, or polycarbonate could be utilized. A polymer with encapsulated iron oxide (e.g., magnetite) could be utilized as well.
- The cover also could be fabricated from a variety of glasses and fused quartz. Polymeric materials which could be advantageously utilized include: polycarbonate, PET, PETG (glycol-modified polyethylene terephthalate), acetate, acrylonitrile, and cellulose nitrate. A variety of coextruded films, composites and polymer alloys may also be used. Of primary importance are dimensional stability, stiffness, resiliency, and optical clarity (when required). The ability of a material to be fabricated in thin sheets is also a factor. Methyl methacrylate and polystyrene are both potentially suitable materials but are difficult to fabricate in thin sheets.
- The cover is typically of greater surface area (or projected area) than the reaction volume. The cover may typically assume the same length and width as the spacer (e.g., 2 inches×. 0.5 inches) but could be larger, if required, or smaller.
- Materials which may be utilized to produce a good to excellent overlay include: polycarbonate, PETG, methyl methacrylate, polystyrene and glass. However, glass is difficult to fabricate into the required shapes. Materials which may be utilized to produce a good to moderately good overlay include: polyvinyl chloride, nylon (polyamides), PET or polyethylene terephthalate (e.g. mylar), and acetate. Materials which may be utilized to produce an acceptable overlay include: acrylonitrile, low density polyethylene film, PP/EVA coextruded film, EVA/nylon/EVA coextruded film, PP/EVA/PE/EVA coextruded film, and oriented polypropylene film. Materials which may produce an overlay of marginal acceptability include: XT and high density polyethylene film. In general, the better materials provide better waveguides because they have lower light scatter losses and transmit well in the visible spectrum where the most commonly employed excitation wavelengths may be found.
- There are many adhesives which can be employed to secure the overlay to the cover and base. Acrylic adhesives are generally good. The best adhesives retain some flexibility, are transparent, and have low light scatter losses when cured, pressure treated, or otherwise activated. The length and width of the overlay may be varied over a wide range, but could be typically and approximately 2 inches×0.5 inches on a 3 inch×0.75 inch base. Thickness of the spacer is typically in the range of 0.002 to 0.010 inches. Thinner spacers may occasionally result in impeded capillary channel flow. Thicker spacers tend to lose liquid at the air interface adjacent to the edge of the reaction volume due to poor capillary action at larger diameter conduits.
- The base is a solid support and can be made from a variety of materials. It should be rigid enough to maintain and support the reaction volume geometry, transparent in the reaction volume region (if required for monitoring) and capable of being bonded to the spacer/cover component. Fluorinated hydrocarbons such as Teflon make poor bases because they are difficult to bond. Glass is an acceptable material. Excellent bonding may be achieved with polycarbonate or methyl methacrylate base materials. A typical minimum thickness for the base is approximately 0.020 inches for a material such as polycarbhonate. An aluminum base (if transparency is not required) could be thinner. If the base is too thin, it may bend too easily and alter the volume of the reaction volume unintentionally during handling or manipulation during an assay. If the base is too thick, it may take too long to achieve thermal equilibrium for a temperature controlled assay. This is especially true for materials with low heat conductivities. The length and width of the base are variable. The base could be as small as 0.25 inches in width and 1 inch in length (or even smaller). Typically, the base will be approximately 0.75 inches in width and 3 inches in length. This provides enough room for a sample well, connecting conduit, and reaction volume with vented end. There would also be an area to grip the slide with thumb and forefinger for handling and placement and another area for an optically or magnetically readable code to provide information to the analytical instrument employed. This information might include the type of assay, control parameters, calibration information for that batch of reagent, etc. As will be described later, the base could be wider (or longer) if multiple assays are to be performed on the same sample. In such a case, multiple reaction spaces might be used in parallel (or series) communication with the sample well. The base could consist of a composite material (e.g., two layers, such as a lower layer of aluminum, iron, or other metal with a hole under the reaction volume. Atop this layer and affixed thereto would be an upper layer of transparent material, such as polycarbonate, which would define the bottom of the reaction volume to allow light transmission through the hole in the lower layer.
- When used, the reflective layer (78, 80 FIGS. 10, 11) can be made by applying a thick film of aluminum paint. Other methods include chemical deposition of silver metal and vacuum vapor deposition of silver or aluminum. Another fabrication technique is to employ metallized heat sealable film, for example, metallized linear low density polyethylene (LDPE) film of approximately 20 microns thickness (or less). Other metallized polymer films may also be utilized if coated with a heat sealable material such as polyvinylidene chloride. An example is metallized heat sealable polypropylene film (polypropylene coextruded with heat sealable materials). Other possibilities include metallized cellophane coated with a heat sealable material. Metallized films may be heat sealed or glued with an adhesive (e.g. cyanoacrylates) to the base and cover of the reaction slide. Metallized glass may also be utilized.
- As stated above, a currently preferred method of use of a reaction slide according to the current invention involves the use of one or more sources of light external to the reaction slide and one or more light detectors external to the reaction slide. Illustrative examples of such instrumentation and use will now be described.
- Shown in FIG. 19 are a transverse vertical cross-section of a preferred embodiment of an external
light source 120, a transverse vertical cross-section of a representative embodiment of areaction slide 1, the cross-section being taken in the region of thereaction volume 66, and alight detector 121 disposed beneath thereaction slide 1 in the area of thereaction volume 66. A driedreagent 125 is deposited on the walls of thereaction volume 66. - In this embodiment, the
light source 120 comprises aplastic housing 130 supporting anLED 132 having electric leads 134. As shown, astep 136 is formed inhousing 130. As shown, thecover 10 may be made of an opaque material such as a metal. - In use, the
light source 120 andreaction slide 1 will mate such that thestep 136 receives thebase 30 of the reaction slide and theLED 132 is disposed above thebase 30 and in contact with or closely adjacent aninternal waveguide 27 of the reaction slide. - The arrangement illustrated in FIG. 19 is designed to employ a light path such as that shown at41 in FIG. 4. A more detailed example of instrumentation for accomplishing such measurement is shown in FIGS. 20 and 21.
Housing 140 compriseslower housing 142 and cover 144 resting on or integral withlower housing 142. A lower end ofwall 146 ofcover 144 is spaced from the top 148 oflower housing 142 by a distance which is sufficient to allow thereaction slide 1 to be inserted. Lateral guides 150 and stop 152 establish a proper position ofreaction slide 1 for a measurement.Light source 120 andlight detector 121 are disposed within thehousing 140, as shown. There is provided in the top 148 of the lower housing anopening 154, disposed immediately beneath the reaction volume of the reaction slide such that light passing through thebase 30 of the reaction slide may reach thelight detector 121. - Sample well64 of
reaction slide 1 is disposed outside thehousing 140, such that thereaction slide 1 may be inserted into thehousing 140 before a reaction is initiated. - The
light detector 121 may be used to monitor the progress of sample entry into thereaction volume 66 and the subsequent progress of the reaction within thereaction volume 66. Thelight source 120,reaction volume 66 andlight detector 121 are disposed in a portion of the instrument that is isolated from ambient light. Desirably, those portions of thereaction slide 1 which are exposed to ambient light are made of opaque materials or are painted so as to aid in the exclusion of stray light from thereaction volume 66. - Temperature control is provided for the reaction slide by means of heaters of a thermal control system, illustrated schematically as
element 156. One form of such a heater may be aconductive heater strip 157 fastened to the bottom ofplate 148. Regardless of the form of thermal control system used, it is desirable that it be capable at least of maintaining the temperature of theplate 148 at 37° C. - The instrument shown in FIGS. 20 and 21 is not of a standard commercially-available type but is instead custom designed for use with reaction slides. As in the case of other instruments currently available for decentralized testing, optical or magnetic code reading capability is preferably present to provide for identification of the assay to be performed and of the particular reaction slide being used, along with calibration. information. Such a code may be affixed to the reaction slide during manufacture. In addition, other structure may be present to provide for mixing when required (to be described below). As also described below, there will desirably be associated with the illustrated instrumentation a system microprocessor, display or other data presentation means, any necessary analog-to-digital converters, power supplies, and the like.
- As may be seen from a consideration of FIG. 21, it is desirable for the spacing between the lower end of
wall 146 and theplate 148 to be as low as possible to aid in the exclusion of ambient light. Accordingly, this embodiment of instrumentation is not conducive to the use of a reaction slide that is provided with aLAM assembly 50 as shown in FIG. 6. Therefore, there may be provided within the housing 140 a movable structure for advancing and withdrawing a separate LAM from thevent 76. - One type of assay that may advantageously be conducted using the apparatus illustrated in FIGS. 20 and 21 is a measurement of prothrombin time. Illustrative results of such a measurement will now be described with reference to FIG. 22.
- FIG. 22 shows a resulting light scatter curve obtained when a plasma sample is deposited in the sample well64 of a reaction slide containing dried thromboplastin calcium reagent. This curve is unexpected and quite different from the 900 light scatter signal observed for the same assay using liquid reagents. The same type of photodetector was employed in earlier work with liquid reagents. See for example Oberhardt, B. J., Monitoring System for Fully-Automated Prothrombin Time Determination, Digest of the 7th International Conference on Medical and Biological Engineering, Stockholm, Sweden, 1967, p. 187, which is hereby incorporated herein by reference. With liquid reagents, however, different and considerably less informative curves result. An apparatus using the same photodetector as in the present invention and which employed liquid reagents to produce the previously published curves is disclosed in U.S. Pat. No. 3,450,501. This patent is hereby incorporated herein by reference.
- In prothrombin time determinations that are performed with liquid reagents and plasma samples, the scatter intensity curve starts off low, increases upon addition of reagent, and increases further at the formation of the gel clot.
- The different result obtained with dried reagent may possibly be explained as follows, although the present invention is by no means to be construed to be limited by the following explanation which is simply given to illustrate one current plausible explanation of the results obtained with the present invention. In accordance with the illustration of FIG. 22, the sample rapidly propagates through the
conduit 26 and into thereaction volume 66. The liquid front advances swiftly, filling the reaction volume, solubilizing thereagent 125 and initiating the coagulation reaction. The light intensity (FIG. 22) as detected by thephotodetector 121 is initially high at the level indicated at 160. This is presumed to be because the dried reagent is highly refractile. Upon addition of sample at a particular point in time, 162, the light intensity drops precipitously as shown at 164 due to dissolution of the reagent, which apparently provides an improved refractive index match. Elimination of air as the sample moves into the reaction space probably contributes significantly to matching of refractive indices. The decreasing scatter curve may then level off before the beginning 166 of adiscernable rise 168 is observed. This rise may be due to the increase in scattered light intensity arising from the polymerizing system which at or near this point in time has formed a gel clot. The scatter intensity continues to increase more slowly, 170, eventually levelling-off. - The prothrombin time is equal to or highly correlated with the time elapsed between
sample addition 162 and theclot formation endpoint 166. Prothrombin time (interval 172) is shown below the abscissa as 15 seconds (for the particular assay illustrated). It is believed that this is the first successful example of a prothrombin time determination being performed via light scatter measurements with dry reagent. - FIG. 23 shows a simplified systems block diagram of how the analog signal in FIG. 22 may be interpreted. The
light source 120 transmits light through thereaction slide 1. Light scatter at 90° is monitored by thephotodetector 172 and amplified at 176. Digitizing is accomplished at 178, and peak and slope detection are accomplished inblock 180. At 180 start time and endpoint detection are determined, as well as kinetic curve characteristics. The resultant digital information is sent to the microprocessor CPU, 182, which has other inputs and outputs 184.Block 186 contains data and program memories. The results are read on thedisplay 188. In addition to monitoring the assay kinetics, the dynamics of sample entry into the reaction space and initial interaction with the reagent are monitored, as well, as a consequence of the geometry and structure of the reaction slide. The initial fall of the curve therefore provides information for quality control of proper sample addition. - The above is an example of a measurement made by light scattering. There will now be described an example of a measurement made by reflectance. In this particular example, changes in reflectance are used to monitor viscosity changes during a coagulation reaction. Shown in FIG. 75 is a
reaction slide 1 disposed above and in close proximity to apermanent magnet 195. Beneath thepermanent magnet 195 is anelectromagnet 196 which is driven by apower supply 199 for cycling voltage on and off at a desired frequency. There is also provided a light source for providing incident light and a detector positioned for detecting light rays reflected from the sample within thereaction volume 66. - The reflected rays illustrated as
rays 198 are detected by adector 400.Detector 400 can be positioned at any position between the 90° and the 10° positions, inclusively, shown in FIG. 75. Preferablydetector 400 can be positioned between 90° and 45°, most preferably between 90° and 75°. A measurement that has successfully been conducted with such apparatus will now be described. - The reaction slide was prepared in advance by forming a slurry of a coagulation reagent and inert magnetic particles suspended in the reagent. The coagulation reagent was thromboplastin-calcium, and the magnetic particles were magnetite. Inert magnetic particles work well when provided in the range from approximately 5 to 50 milligrams per milliliter of liquid reagent. The slurry was applied to the reaction slide and freeze dried.
- To perform the assay, the
reaction slide 1 was introduced to the apparatus in position as shown in FIG. 75. The light source was a light emitting diode, and the detector was a silicon photodiode. A chart recorder was AC-coupled to a photodiode amplifier. Thepermanent magnet 195 was in the form of a sheet (which may be made of a flexible or rigid magnetic material). The power to the electromagnet was cycled at a frequency of 1 Hertz. A sample of blood plasma was introduced into the sample well 64 and filled thereaction volume 66, solubilizing the dry reagent, resuspending the magnetic particles as shown at 197, and iniating the coagulation reaction. Thepermanent magnet 195 causes the magnetic particles to be drawn downwardly and lie down against the base 30 in an orientation parallel to the plane of the permanent magnet. However, each cycle of energy supplied to theelectromagnet 196 causes the magnetic particles to stand upright like tiny whiskers in an orientation of alignment along vertical field lines. At the end of each such energy cycle, the particles lie flat again. - The detected reflected light198 shows a time-varying pattern of light intensity in accordance with the above-recited changes in orientation of the magnetic particles. The light intensity is less when the particles lie flat than when they stand upright.
- The detected light intensity shows an initial peak at sample addition. Thereafter, the detected light intensity cycles between maximum and minimum values in accordance with the frequency of the cycling of the
electromagnet 196. During the period before clot formation, the difference between the maximum and minimum values of the detected light intensity increases. However, the peak-to-peak light intensity oscillations begin to fall off from their maximum values when a clot has started to form. At this point, the endpoint has been reached. In the case of prothrombin, the elapsed time between the sample addition peak and clot formation or clot onset (endpoint) is easily measured. Resolution may be increased by increasing the oscillation frequency. - For determining prothrombin time, the above-described approach works extremely well using whole blood as well as plasma. It is expected to work well for other types of blood coagulation assays. The measurement may be made using transmitted light instead of the described method of using reflected light. However, it is thought less convenient to use transmitted light than reflected light.
- The above provides one example of a light scattering measurement followed by one example of a light reflecting measurement. Alternative means for introducing light into the
reaction volume 66 for such measurements will now be discussed together with a discussion of other types of optical measurements. In particular, there will be discussed optical measurements based on transmission/absorbance, chemiluminescence, reflectance, fluorescence, and combinations of these techniques. - Transmission/absorbance, or optical density measurements, involve measurement of the ratio of light intensity before and after light passes through a sample in the absence of (or excluding) scattering. The Beer-Lambert Law describes the phenomenon. Standard detectors are employed in a “line of sight” configuration with the light source, as shown in FIG. 25. Incandescent or LED light sources may be used.
- FIG. 25 also illustrates an alternative means of introducing light into the reaction slide and of measuring light that has left the reaction slide. In particular, there are provided two
external waveguides internal waveguides 27 of thereaction slide 1 and receive light that has been passed through the otherinternal waveguide 27 and channel the received light to thephotodetector 121. Theexternal waveguides overlay 20 of a reaction slide, as described above. Accordingly, it may be seen that use of an external waveguide orwaveguides reaction slide 1 that is alternative to thepolymeric housing 130 illustrated in FIG. 19. - An
optical filter 192 may be used for wavelength selection. - In FIG. 25, colorimetric or turbidometric measurement is achieved. Light rays pass through
filter 192, travel throughexternal waveguide 190 and through aninternal waveguide 27, then illuminatereaction volume 66. They pass through the reaction volume, through theinternal waveguide 27 at the right, and are transmitted through optional secondexternal waveguide 191. The light rays are then directed to anappropriate detector 121. - In FIG. 26, a second
light detector 121 for detecting scattered light and anaperture 194 to restrict detection to light scattered at or near 90° have been added to the arrangement of FIG. 25.Aperture 194 is analogous toaperture 154 of FIG. 22. FIG. 26 therefore illustrates an embodiment which allows simultaneous detection of scatter and absorption. It is based upon a combination oflight paths - FIG. 27 shows an embodiment employing a
reaction slide 1 with a transparent base anddetector 121, but no light source other than that initiated by a chemiluminescent reaction taking place within the reaction space. The chemiluminescent reaction can be triggered upon the addition of sample. - FIG. 28 shows an embodiment based upon reflectance. A partial integrating sphere200 mounts a
light source 120 and alight detector 121. The partial integrating sphere is positioned beneath thebase 30 of areaction slide 1 having areaction volume 66 andcover 10. Rays reflected back into the partial integrating sphere from within the reaction slide are detected to allow measurement of the reaction. It should be noted that thespacer 60 is not employed to provide internal waveguides for transmission. Internal waveguides are not necessary for the type of measurement performed in FIG. 27, either, but they can of course be used, if desired, by positioning a detector so as to intercept light exiting through an internal waveguide. - More generally, such reflectance measurements capture light reflected in any desired direction from surfaces or surface layers. A photodiode or photo-conductive cell may be used along with a filter for wavelength specificity. The Kubelka-Monk Theory is a useful model for reflecting systems.
- A further method of detection may be based upon fluorescence and involve the use of materials which are fluorescent and hence absorb ultraviolet light and emit light of a longer wavelength, frequently in the visible range. Fluorimetry may be used in a reflective mode, similar to photodensitometry, for example to quantitate samples on chromatograms. Variations are possible, together with the use of fluorescence in combination with other modes of detection. For example, a detector may be placed at a fixed angle, typically 90°, from the direction of transmission through a sample, as in nephelometry. As will now be described in connection with FIGS. 29 and 30, fluorescence also may be detected using an evanescent wave, for example at a solid/liquid interface. Light paths such as those shown at42 and 43 in FIG. 4 may be used.
- FIG. 29 illustrates how a
reaction slide 1 may be used to perform fluorescent evanescent wave measurements near a wall (cover/liquid interface) and alternating with or simultaneous with colorimetric (or fluorescent) measurements through thereaction volume 66. Afirst prism 202, which typically is not part of the reaction slide but rests on top of thecover 10, is affixed to and mechanically supported by firstexternal waveguide 190 which, in turn, rests atop thebase 30 of thereaction slide 1. Fluorescent light rays 42 are refracted byprism 202 and emerge, entering thecover 10 at an angle somewhat greater than the critical angle. Therays 42 undergo total internal reflection within thecover 10, as shown at 206, and produce intense evanscent waves at the interface between thecover 10 and the liquid in thereaction volume 66. The evanescent waves excite fluorescent molecules bound at or near the wall as a result of selective binding (or, depletion) associated with an assay. The total internal reflected light then passes out of the cover and is removed bysecond prism 204 situated atop secondexternal waveguide 191, passing out of the system. Fluorescent emission of light is detected by adetector 121 positioned beneath the transparent base of the reaction slide. -
Light ray 40 is sent into the system throughexternal waveguide 190 andinternal waveguide 27, to illuminate thereaction volume 66. It emerges through the oppositeinternal waveguide 27 and secondexternal waveguide 191, exiting to be detected by adetector 121 positioned laterally of the reaction slide. - Illumination rays40 and 42 would typically be of the same or similar wavelength but could excite molecules with different emission spectra. In this figure, the
detector 121 disposed beneath thebase 30 is shown to detect fluorescence emission resulting from either excitation ray. Twin detectors could be utilized, as well. Convection currents are created within thereaction volume 66, using any technique to be described later. - The arrangement in FIG. 29 allows monitoring of the progress of complex reactions involving bulk liquid species undergoing reactions and simultaneous receptor site interactions at the wall.
- FIG. 30 shows another arrangement using evanescent wave fluorescent detection. One application of this arrangement is rapid measurement of hematocrit in a blood sample. In this case,
prisms base 30 of the reaction slide to produce total internally reflected light 206 from theinitial ray 43.Spacer 60 is not used in this example to transmit light. Adetector 121 is positioned beneath the base 30opposite reaction volume 66. A highly soluble fluorescent dye is reversibly absorbed to the cover wall or base inside the reaction volume. The dye may also be contained in a highly porous space-filling soluble hydrophilic polymer with capillary or Interstitial structure. The fluorescent dye is chosen such that it neither enters nor adheres to the blood cells and is compatible with the blood plasma. In general, most fluorescent dyes with net negative charge in solution will be suitable, since they will not bind to or adsorb to the surfaces of red blood cells and platelets (which have negative surface charge). The exceptions are dyes that can enter the red cells. These exceptions may generally be rendered suitable by covalent bonding to an appropriate larger molecule (e.g. dextran or polyglycols). - When the blood sample enters the
reaction volume 66, the dye is rapidly dissolved in the plasma, the rapidity of dissolution being aided by the flow dynamics through the tortuous paths in the space filling soluble polymer and/or by electromechanical mixing effect, to be described below. The fluorescent signal near the wall therefore quickly approaches a steady state, indicative of the concentration of fluorophore in the plasma. From this concentration, the known volume of the dye (and polymer, if employed) and the volume of the reaction volume, the plasma volume and hematocrit can be readily calculated. - Fluorescent dyes which may be possible candidates for use in the hematocrit determination application may include: rhodamine B, berberine sulfate, ethidium bromide, methylene blue, thionine, and others, such as cyanine dyes (e.g., 3,3′-diethyloxadicarbocyanine).
- The method of hematocrit determination by dye dilution is old (Eric Ponder,Hemolysis and Related Phenomena, Grune & Stratton, New York, 1948, pp. 51-53). It has been applied in various forms, such as in a continuous flow analyzer (Oberhardt, B. J. and Olich, J., U.S. Pat. No. 4,097,237). Recently the method has been applied using evanescent-wave fluorescence in a capillary tube (Block, M. J. and Hirschfeld, T. B., European Patent Application, Publication Number 0128723; Application Number 84303759.9; filed Jun. 5, 1984; published Dec. 19, 1984).
- The present invention is an improvement in that it utilizes a self-contained convective effect to rapidly dissolve or aid in dissolving the dye, thereby yielding more rapid test results than would be otherwise possible. Additional improvement is afforded in terms of increase in the accuracy of the determination in the laterally flowing system created by forced convection, to be described more fully below. In this flowing system, when lateral flow is alternatively established, blood cells (particularly erythrocytes) will on the average tend to rise to the center of the stream due to hydrodynamic lift forces. This removal of cells from the excitation region of the evanescent wave, however brief, provides an interval for eliminating cell interference artifacts in the fluorescence measurement.
- Various exemplary methods for inducing forced convection currents within the
reaction volume 66 of areaction slide 1 will now be described with reference to FIGS. 31-34. Such forced convection currents promote rapid and thorough mixing. - In FIG. 31 is shown a fine paramagnetic mesh or
screen 208 disposed within the reaction space. Thescreen 208 may be supported by sandwiching it between thecover 10 andbase 30. In the embodiment shown, the lateral edges of the screen are pressed against anoverlay 20 by an upper adhesive layer. Themesh 208 must be capable of undergoing translational movement or bending while being confined within thereaction volume 66. - The mesh may be a metallized polyester screen having a coating, for example, of nickel. Other embodiments are possible. For example, the screen may be made of nylon or polyester, coated with a dispersion containing magnetic iron oxide. In the alternative, the screen itself may be made of iron or steel and may be coated with a protective plastic coat such as an elastomeric coating. As an alternative to a mesh, a solid flexible support may be used, with a distributed array of magnetic particles such as magnetite coated with inert polymer bound to the solid support.
- An oscillating magnetic field is supplied by
electromagnet 210 connected to an appropriate time-varyingelectrical power source 212. Under the influence of this magnetic field, the mesh undergoes mechanical oscillations which translate to the development of continuous oscillatory flow in the liquid contained within the reaction volume for as long as the driving signal is applied. The induced flow can be used to: (i) maintain a steady state level of convection in a reaction volume containing sample and reagents; (ii) assist in rapidly dissolving a reagent; or (iii) increase convection near the wall (cover or base) to facilitate transport of species to bound reagents. - FIG. 32 shows an alternative arrangement for mixing. In this figure,
permanent magnet 214 is affixed to cover 10 and driven into an up/down oscillation byelectromagnet 210 supplied by an electrical driving signal from 212. Thecover 10 moves along with themagnet 214 as essentially one unit, causing periodic alterations in the volume of thereaction volume 66. The inflow and outflow of liquid produces mixing. The mixing resulting here is well suited for moving liquid in the vicinity of the cover/liquid interface. To achieve this type of mixing, thecover 10 may be fabricated from a thin paramagnetic material, obviating the need for aseparate magnet 214. If a separate magnet is used, it may be doughnut shaped, or disc shaped. It may also be made of flexible ceramic magnetic material. A similar arrangement also is illustrated in FIGS. 29 and 30. - FIG. 33 shows an arrangement which provides yet another alternative for producing and sustaining a controlled convection within the
reaction volume 66. In this case, asolenoid 216 is employed, having arod 218 and a coil which is driven by an appropriate intermittent unidirectional or time varyingcurrent source 220 to pushrod 218 against and deflect thecover 10. The solenoid may be spring-loaded to retract the rod upward after cessation of the current. - In the alternative and as shown in FIG. 34, there may be provided a projecting
element 222 passing through ahole 224 in anorbiting disk 226.Tension spring 228biases projecting element 222 downwardly as shown in the drawing. Drive 230 initially movesdisk 226 downwardly for contact between the projectingelement 222 and thecover 10 of a reaction slide. At such time, projectingelement 222 pushes againstcover 10 at a localized pressure point with a force, the magnitude of which is governed byspring 228. Thereafter, drive 230 rotatesdisk 226 about the axis thereof, causing the localized pressure point to trace a circle on the upper surface of thecover 10. Thecover 10 accordingly experiences a localized deflection that moves in a circular pattern, following the position of the projectingelement 222. Such localized deflection of thecover 10 causes mixing in thereaction volume 66. It has been found that a deflection of 0.005 inches may be produced in apolycarbonate cover 10 by a force of 3 ozs., applied with a projectingelement 222 having a 0.100 diameter circular cross-section and a rounded bottom. - Yet another approach to mixing (not shown) is to utilize a cover fabricated from a piezoelectric material or containing a piezoelectric material affixed thereto. In this case, motion of the cover would be produced piezoelectrically by application of the appropriate voltage.
- As noted above, a reaction slide according to the current invention may be used to conduct assays in which the results are measured using non-photometric techniques. That is, in addition to transduction of light energy (e.g., transducers of the photoconductive, photodiode or photomultiplier type), the reaction slide may employ other mechanisms for energy conversion. Additional types of transducers that are applicable to a reaction slide according to the current invention include calorimetric transducers, electrochemical transducers and viscosity transducers. Examples of these will be described with reference to FIGS.35-37.
- Shown in FIG. 35 is a transverse vertical cross-section of a representative embodiment of a reaction slide according to the current invention.
Calorimetric transducer 232 such as a thermistor, thermocouple or thermopile is mounted by thebase 30 of the reaction slide such that at least a portion of thetransducer 232 is directly exposed to thereaction volume 66. Electric leads 234, embedded in thebase 30, extend from thetransducer 232 toelectric contacts 236 mounted on the base 30 in a known manner. For example,electric contacts 236 may be a conventional thick-film polymer having contained therein a conductive powder. Appropriate instrumentation is attached to theelectric contacts 236. - The
calorimetric transducer 232 may be used to measure temperature change or heat input or output in an isothermal system. Thus, the heat generated during a chemical reaction may be monitored and used to quantify analyte concentration using information related to heat of reaction. - As explained in-more detail below, a reaction slide according to the current invention may be configured to allow liquid to enter and exit the
reaction volume 66 at predetermined times. In such a case, using acalorimetric transducer 232, temperature may be measured before and after residence of the sample in the reaction volume. During residence, a known amount of heat may be transferred to the liquid, as by aresistive heater 238 in thebase 30 of the reaction slide. From the temperature change (before and after heat input) the specific heat capacity of the liquid (and analyte concentration for a pure dissolved analyte and moderate concentration) may be measured using well-established procedures. - The use of electrochemical transducers will now be described with reference to FIG. 36, which is a top view of a reaction slide according to the current invention with the cover removed. First and
second electrodes reaction volume 66 and are spaced from each other. In the embodiment shown, theelectrodes electric lead 244 extends from each electrode toelectric contacts 246 formed on thebase 30 of the reaction slide, taking care that the lead from theinner electrode 242 does not make contact with theouter electrode 240. - Such electrochemical transducers may be of the potentiometric type (e.g., pH measuring electrodes). In such a case, a voltage may be generated which is proportional to the analyte species concentration.
- Also, amperometric methods may be employed, for example using vacuum vapor deposited gold and silver. A polarographic system may be used, which is a current measuring system having two or three electrodes, such as a reference electrode, working electrode and measurement electrode. An example is an amperometric potentiostat. Such a system may be used with the application of various voltammetric sweep patterns, depending upon the analyte species to be detected.
- Conductivity methods also may be applied. In such a case, an electrode in the presence of an analyte exhibits a change in conductance or resistance. Examples of this type include electrodes fabricated from low dimensional materials such as polyacetylene, polypyrrole, and the like.
- Enzyme electrode systems and antibody electrode systems also may be used.
- FIG. 37 illustrates the use of a viscosity transducer. There is shown a
strain gage 248 mounted on thecover 10 of areaction slide 1. Using thestrain gage 248, the rate of bending or movement of thecover 10 or, in the alternative, the rate of recovery from a downward push imparted by a solenoid-actuatedpush rod 250 may be measured. Changes in the viscosity of fluid in thereaction volume 66, such as occur in coagulation reactions within the reaction space, may therefore be measured using viscosity monitoring. - Viscosity monitoring is useful with a type of measurement to be described below in which there is established a constant flow of liquid into and from the
reaction volume 66. An increase in the viscosity of the liquid within thereaction volume 66 results in increased drag and in retardation of motion of the cover. - As an alternative to the use of a
strain gage 248 in viscosity measurements, there may be used a piezoelectric element mounted on thecover 10. - As has been noted above, a reaction slide according to the current invention provides for the storage of a pre-measured amount of reagent. One manner of providing for the presence of a reagent has already been described in which a liquid reagent is placed in the reaction volume and then dried, such that the dried reagent coats the interior surfaces of the reaction volume. Other methods will now be described with respect to FIGS.38-41 and 61. Shown in FIG. 38 is a longitudinal cross-section of a portion of a
reaction slide 1 according to the current invention. There is shown a reagent-containinglayer 252 disposed on the base 30 in the region of thereaction volume 66. If desired, the reagent-containinglayer 252 may extend further to the left than shown, occupying the regions of the taperingwalls 25, theconduit 26 or even extending into the sample well 64. Although the illustrated reaction slide is of the type that vents laterally (that is, there is no vent opening in the cover 10), areagent layer 252 may be used with any embodiment. - FIG. 39 is a fragmentary vertical cross-section taken in the region of the reaction volume of FIG. 38 and illustrating a first specific embodiment of a reagent-containing
layer 252 as shown in FIG. 38. In particular, thereagent containing layer 252 is in the form of a reagent-containinggel 254. - FIG. 40 is a similar view, showing a second embodiment of a reagent-containing
layer 252. In particular, thelayer 252 comprises anupper layer 256 of a thin porous hydrophilic (semipermeable) membrane. Themembrane 256 is attached to thesecond layer 258, which is in the form of a liquid absorbing matrix (LAM). - The embodiment shown in FIG. 40 is especially useful for plasma separation when whole blood is used as the sample. Iii particular, plasma is drawn through the
membrane 256 and into theLAM 258, where it is stored. Further details of such an assay will be described later. Variations of this embodiment are possible, according to which thelayer 252 may comprise theLAM 258 having thereon a thin coating of polymer to provide a finer pore structure at the upper surface of the LAM, such that the upper skin of the LAM performs the same function as performed by themembrane 256. That is, the fine pores of the thin polymer coating exclude cells but admit plasma. Alternatively, theentire layer 252 may consist of a single layer of a fine pore sponge. - FIG. 41 is a fragmentary vertical cross-section of an additional embodiment of a reaction slide according to the current invention, taken in the vicinity of the
reaction volume 66. This embodiment also is useful where whole blood is the sample and is used for initiating a reaction at a desired time after plasma separation is achieved. Acavity 260 is formed in thebase 30 of the reaction slide. Disposed in the bottom of thecavity 260 is a reagent-containinglayer 262, on top of which is an inertannular spacer 264. Disposed above thespacer 264 is aLAM 258, there thus being formed a gap between theLAM 258 and the reagent-containinglayer 262. Plasma-separatingmembrane 266 is disposed in thereaction volume 66 in contact with theLAM 258. - With whole blood in the
reaction volume 66, plasma will be drawn throughmembrane 266 and stored inLAM 258. After such separation is achieved, a reaction may be initiated at any desired time by manually or automatically (for example, as with a solenoid driver) pushing down oncover 10 to cause contact between theLAM 258 and the reagent-containinglayer 262. Such contact will initiate a reaction at the desired time. - FIG. 61 is a longitudinal cross-sectional elevation of a reaction slide according to the current invention, showing yet an additional method of incorporating a reagent into a reaction slide.
Reaction volume 66 is filled with a permeable polymeric matrix 270 having a reagent distributed throughout the matrix. It is a matter of choice whether or not the matrix 270 extends to the right as shown in the drawing into the region of thevent 76 or all the way to the left in the drawing as far as the sample well 64. The use of such a dry porous space-filling reagent in the reaction volume provides capillary or interstitial fine structure that is capable of controlling the filling beyond the control provided by the capillary flow ordinarily arising from the spacing of thecover 10 andbase 30. - It will be noted that performing an assay typically begins with the introduction of a sample into a sample well64 of a reaction slide. FIG. 42 illustrates an additional embodiment of a reaction slide according to the current invention, the embodiment being useful as a “processing device” for initiating an assay at any desired time by depositing a sample into a sample well of another reaction slide at the desired time.
- A
passage 272 extends from the lower surface ofbase 30 upwardly to arecess 274 of greater lateral dimensions. Disposed in therecess 274 are aplasma separating membrane 266 and aLAM 258. With whole blood filling thereaction volume 66, plasma passes throughmembrane 266 and is collected inLAM 258. Either before or after such separation, the slide shown in FIG. 42 is positioned above a second reaction slide in which the assay is to be performed. In particular, it is positioned such that thepassage 272 lies directly above the sample well 64 of the second reaction slide. At the desired time, thecover 10 of the slide shown in FIG. 42 is depressed, and such depression will result in the expulsion of a drop or droplets of plasma fromLAM 258, throughpassage 272 and into the sample well of the second reaction slide to initiate the assay. - As has been discussed above, the various embodiments of reaction slides according to the current invention are useful in performing a variety of assays. A prothrombin time determination has been described above. More specific examples are given below in Examples 1-7. There will now be described what may be called a continuous flow assay involving the separation of cells in a flowing stream. The embodiments of FIGS.38-41 are especially useful for such assays. An important conceptual difference between such assays and those in which the sample remains in the reaction volume 66 (such as the prothrombin time determination) is that, in a continuous flow assay, there is a comparatively larger volume of sample available in the sample well 64, and a continuous flow is established from the sample well 64 to the
LAM 82. To this end, it may be desirable to enlarge the available volume of the sample well. FIG. 38 shows one way in which the sample well 64 may be enlarged. In particular, annularsample well extender 276 is fixed atop thecover 10 of thereaction slide 1 to increase the volume of the sample well 64. Other means of accomplishing this result may present themself to those of ordinary skill in the art. - A liquid sample is placed in the sample well64. This sample rapidly flows to the right in FIG. 38, filling the
conduit 26 and thereaction volume 66. Upon contact of the liquid with theLAM 82, a flow condition is set up whereby the liquid is pulled in and flows continuously into theLAM 82 until the sample well 64 is exhausted. - The established laminer flow condition is advantageous for analysis or processing of certain types of samples, such as samples with suspended particles (including but not limited to whole blood). A characteristic of the continuous flow is that suspended matter moves away from the top, bottom and side walls of the passage in which it flows and toward the center of the stream. Such material accordingly does not participate to a substantial degree in chemical, enzymatic or immunological reactions caused by reagent-containing
layers 252. Thus, the laminar flow condition driven by theLAM 82 provides a separation step. Color development may be read in thereagent layer 252 in a variety of ways, such as the use of reflectance measurement technology illustrated in FIG. 28. - In a continuous flow measurement, when the sample is blood, an embodiment similar to those described above in regard to FIGS. 40 and 41 is desirable. The pore structure used for passing plasma and excluding blood cells should be such that the pores have a size of approximately 1.2 microns or less. For the use of whole, non-anticoagulated blood, anticoagulant may be present, if required, in
LAM 82 and possibly in the vicinity of or contained within the reagent-containinglayer 252. - Separation of cells (or particulates) in a flowing stream from the medium in which the cells are suspended may be achieved under the appropriate flow conditions, since the cells migrate away from the walls of the conduit and toward the center of the stream. As disclosed by B. A. Solomon (Membrane Separations: Technological Principles and Issues, Vol. XXVII, Trans. Am. Soc. Artif. Organs 1981 pp. 345-350), blood flow sustained parallel to the plane of a suitable membrane allows plasma to be drawn through the pores of the membrane without damaging the cells, due to the tendency of cells to migrate away from the membrane surface. In the present invention, the sustained transverse flow is achieved not by pumping or vacuum (pressure differentiation) induced by mechanical means but through the use of a fine capillary or absorbant structure (LAM) to remove liquid (e.g., blood) and thereby to cause movement or flow in a direction parallel to the plane of the membrane. At the same time, a capillary action through the membrane and into a second Liquid absorbing matrix (LAM) is achieved to collect the separated blood plasma on the opposite side of the membrane. The reaction volume dimensions provide a conduit or chamber such that the flowing liquid develops shear forces sufficient to minimize passage of cells through the membrane and hence to minimize cell destruction. The second LAM may contain reagents for performing an assay. The second LAM may be utilized only for collection (and could contain anticoagulants, preservatives, etc.). Diagnostic reagents could be bound to the membrane or contained in another layer adjacent to the membrane or LAM.
- The art of removing a plasma sample from whole blood using a separating matrix and later contacting it at a precise time with a reagent layer has been described for use with a gel or porous medium (Oberhardt, B. J., U.S. Pat. No. 4,288,228, Sep. 8, 1981) and later (by Vogel, P., et al., U.S. Pat. No. 4,477,575, Oct. 16, 1984) for use with a glass fiber layer. The present invention shows yet another way to achieve the objective of plasma separation and reaction initiation at a precise time.
- FIGS.43-60 show how a reaction slide may be utilized to perform an assay involving a bound reagent, several added reagents, and washing steps. An ELISA type immunoassay and-the embodiment of FIG. 6 are used as an example. In FIG. 43, a sample to be analyzed is placed in the sample well. At the bottom of the reaction space is a
layer 252 of covalently attachedantibody molecules 278. This layer is better visualized in FIG. 52, to the right of FIG. 43. A moveable sponge orLAM 51 which forms part of the disposable reaction slide is situated on the base and fastened by any of a variety of mechanisms to allow it to be moved by an external mechanical driver to alternately engage and disengage the LAM from thevent 76 of thereaction volume 66. - FIG. 44 shows the sample filling the reaction volume. FIG. 53 shows greater detail indicating the capture of
antigen molecules 280 by the boundantibody 278. Some unboundantigen 282 and othermolecular species 284 are shown, as well. In FIG. 45, the LAM is depressed to remove all liquid from the system and is subsequently returned to its original position. Emptying the reaction volume of liquid can be monitored electro-optically, as previously described. In FIG. 54, the antibody molecules with captured antigen are shown. Although not indicated, it is also possible to introduce into the sample well a buffer liquid and then repeat the step shown in FIG. 45 to achieve a better washing. This washing step with buffer, which is well known in the art, could be repeated, if necessary. - In FIG. 46, reagent is introduced. This second reagent (the first being the bound antibody) is rapidly drawn in (FIG. 47) and consists of an antibody-
enzyme conjugate 286. After a short incubation (FIGS. 48 and 57), some of the antibody enzyme conjugate molecules become bound 288 to a second site on the antigen molecule (with different specificity than the first site) and some conjugate molecules remain free 290. The liquid is then removed in FIG. 49 (as in FIG. 45) with the possible incorporation of additional washing steps with a buffer. In FIGS. 50 and 59, a developer reagent consisting of a fluorogenic orchromogenic substrate 292 or combination of substrate and developer dye is added. FIG. 51 shows the filling of the reaction volume, and FIG. 60 shows the development ofchromophores 294 or other optically detectable species. - Thus, it is shown that the LAM-reaction slide can allow a precise multistep immunoassay to be conducted with imprecise pipetting steps and simplified wash steps. This could be combined with forced convection to facilitate reactions in FIGS. 53, 56 and59 (as shown in previous embodiments utilizing internal mixing). Of major significance is that labor can be significantly reduced with the use of simple and inexpensive instrumentation performing operations on and interacting with the reaction slide.
- As was the case with the embodiment illustrated in FIG. 13, the configuration of the LAM as illustrated in FIGS.43-51 may, if desired, be modified by having the LAM overlap over part of
cover 10. In this other embodiment, the LAM is situated above the base and is in contact with the cover. Removal of fluid from the reaction chamber is achieved by compressing the LAM down towardbase 30 so that. contact is established between the LAM and the fluid in the reaction volume. - Shown in FIG. 62 is a top view of a first embodiment of a reaction slide of a type having plural reaction volumes.
Cover 10, shown partially cut-away in the figure, is provided withopenings 14, used in forming a plurality ofsample wells 64, andrectangular openings 12 formingvents 76 leading to thereaction volumes 66. Thespacer 60 may be any of the types previously described. In the illustrated embodiment, there are provided in the spacer 60 a plurality ofsample receiving openings 22, which also form part of thesample wells 64. Eachsample receiving opening 22 communicates with areaction space 24, also cut from thespacer 60. As in the preceeding embodiments, thereaction space 24 is used in conjunction withcover 10 andbase 30 to form a plurality ofreaction volumes 66. Taperedwalls 25 are provided communicating thesample receiving opening 22 andreaction space 24. - Disposed beneath the
spacer 60 is a base 30, which is visible through thesample receiving openings 22 andreaction spaces 24. - A plurality of
slots 302 are cut through both thespacer 60 andbase 30 and disposed adjacent eachreaction volume 66. Theslots 302 are configured to receive external optical waveguides that extend upwardly through thebase 30 andspacer 60 for carrying light to and from theinternal waveguides 27 formed between theslots 302 and thereaction volumes 66. As above, such light may be used for measurements using colorimetry, light scatter, and similar measurements. - It may be seen that the
embodiment 300 provides dense packing to achieve more reaction spaces per unit area ofcommon base 30. - The
embodiment 300 may be used with a single set of external waveguides, one mixing station and one LAM actuating mechanism (not shown), each of which may be indexed from space to space, as required, to service designatedreaction volumes 66. In the alternative, there may be used a plurality of fixed external waveguides, mixing stations and LAM actuators, and these may be used independently or simultaneously. - As a variation, individual LAM's may be provided on a strip extending from left to right in the drawing, such that depressing the strip causes the LAM's to withdraw liquid from the
vents 12 of eachreaction volume 66 in a single row. In FIG. 62, three such LAM strips would be used, as there are three rows of reaction volumes. - Samples may be added to the
sample wells 64 independently or simultaneously. - Shown in FIG. 63 is a top view of a
second embodiment 304 of a reaction slide having plural reaction spaces. There is provided asolid base 30, acover 10 having asample receiving opening 14 formed therein, and a spacer disposed betweencover 10 andbase 30, the spacer being formed of aU-shaped member 306 and twodividers 308. Theelements base 30. - The sample well64 extends downwardly into the
U-shaped member 306 and communicates throughpassage 316 with each of threereaction volumes external LAM 82 may be provided as shown in FIG. 13. A separate LAM may be provided for each reaction volume, or a single LAM may serve all three reaction volumes. - Addition of liquid sample to sample well64 causes rapid filling of all three reaction volumes. The
center volume 312 fills slightly faster due to its locationadjacent passage 316. If desired, the sample well 64 may be relocated, or other geometric changes may be made to cause each of thereaction volumes - Shown in FIG. 64 is a top view of a
third embodiment 318 of a reaction slide having plural reaction volumes.Cover 10 is provided with asample receiving opening 14, which forms part of the sample well 64. Thespacer 60, of uniform height and disposed betweencover 10 andbase 30, is provided with a cut-out forming threereaction volumes Reaction volume 320 communicates with sample well 64 throughpassage 326, also cut into thespacer 60.Passage 328, cut into thespacer 60, communicatesreaction volume 322 andreaction volume 320.Passage 330 communicatesreaction volume 324 andreaction volume 322. Thedistal end 332 of thespacer 60 is open, such thatreaction volume 324 vents laterally, to the right in the drawing. A LAM may be provided as shown in FIG. 13. - It may be seen that the reaction volumes fill sequentially from sample well64. When it is desired to remove sample from the reaction volumes, a LAM applied to the
distal end 332 of thespacer 60 will firstempty reaction volume 324. It has been found that, if the LAM is suddenly removed, it is possible to bring about the stepwise transfer of sample fromreaction volume 320 intoreaction volume 322 and the simultaneous movement of sample fromreaction volume 322 intoreaction volume 324. Such action may be used to facilitate sequential rections through the translation of contents of reaction volumes laterally through any desired number of sequential reaction volumes. - FIGS. 65 and 66 show a
fourth embodiment 336 of a reaction slide according to the current invention, thereaction slide 336 having plural reaction volumes filled by parallel filling. Among the uses ofreaction slide 336 is that it is useful in conducting a Plasminogen Activator assay. Also shown in FIGS. 65 and 66 is instrumentation useful in conducting the TPA assay. - In
reaction slide 336, thebase 30, the spacer and thecover 10 have been cut out as shown at 338 to form first andsecond legs cover 10 is provided with an opening for the sample well 64 and openings for each of thevents 354 that communicate respectively withfirst reaction volume 350 andsecond reaction volume 352. The spacer is cut out to form the sample well 64 and to formcommon conduit 344 which branches to form first and secondbranched conduits reaction volumes internal waveguides 27 adjacent the reaction volumes. It will be seen that a sample placed in sample well 64 will be drawn by capillary action throughcommon conduit 344 and will then divide, proceeding throughbranched conduits reaction volumes - Also shown in FIGS. 65 and 66 are first
light source 356, secondlight source 358,first scatter detector 360,second scatter detector 362 andtransmission detector 364.Light shield 366 protects thesecond reaction volume 352 from receiving radiation from firstlight source 356. It may be seen that light from first andsecond sources second reaction volumes base 30, whereafter the scattered light is detected at 360 and 362.Transmission detector 364 detects that portion of the light fromsource 358 which has been neither scattered nor absorbed inreaction volume 352. - The various embodiments of reaction slides according to the current invention may be provided with apparatus for accomplishing “selective flow”, according to which the filling of a reaction volume from a sample well may be delayed for any desired length of time after a sample has been placed in the sample well. Such selective flow may be accomplished by selective venting, as will be described with reference to FIG. 67, or by use of a pinch valve, as will be described with reference to FIGS. 68 and 69.
- In selective venting, capillary action is initially prevented by blocking the downstream egress of air. This is most easily accomplished in those embodiments of a reaction slide in which the venting is accomplished vertically, through an opening through the cover. FIG. 67 is a vertical longitudinal cross-section of a
representative reaction slide 1. Thereaction slide 1 includes avent cover assembly 370, thevent cover 370 including acover support 372 and anelastomeric pad 374 attached to thepad 374 is not a LAM and thecover support 372.Elastomeric pad 374 may be made, for example, of silicone or latex. Structurally, thecover support 372 is similar to theLAM support 52 described above in relation to FIG. 6, except that thepad 374 is not a LAM and thecover support 372 continually biases thepad 374 against thevent opening 12, blocking it. - A sample placed in sample well64 will remain in the sample well until such time as the
pad 374 no longer blocks the vent. Such unblocking of the vent may be brought about by liftingcover support 372. Such lifting may be accomplished manually, mechanically or electromechanically. - Modifications are possible. For example, the
cover support 372 need not be attached tobase 30 but may, instead, take the form of a straight element extending to the right in the figure. Any appropriate means may be used to grasp thesupport 372 and lift it. In such a case, it may be desirable to provide a slight adhesive bond between thepad 374 and cover 10 to prevent premature displacement. In the alternative, a vent cover assembly may be contained in an instrumentation housing, completely separate from thereaction slide 1. When the reaction slide is inserted into the housing, the vent cover assembly may be brought downwardly to cover the vent. - FIGS. 68 and 69 illustrate a pinch valve mechanism.
Elastomeric disk 376 is fixed in an opening incover 10, thedisk 376 being disposed directly aboveconduit 26 which connects the sample well 64 and thereaction volume 66. Pinchrod 378, which may be attached to a control mechanism in an instrumentation housing, is vertically movable so as to descend and press the elastomeric disk into thechannel 26, thereby blocking flow from the sample well 64. At any desired time, thepinch rod 378 may be raised to allow the sample to reach thereaction volume 66. - With the incorporation of selective flow by selective venting or a pinch valve mechanism, or both, it is possible to send a liquid or liquids to a reaction volume at a predesignated time or to move liquid streams out of one reaction volume and into another at a predesignated time, as described below. It also is possible to stop the flow of liquid into a reaction volume, for example, when it is partially filled. Among the possible applications are as follows:
- A. A chemical reaction may be initiated at a specific time, such as after a prior reaction has taken place (e.g., for diagnostic assays).
- B. Mixing of two liquids is possible and easy to control, as also described below.
- C. As described below, cascading of reaction spaces may be controlled.
- D. By mixing two liquids, it is possible to perform dilutions (sequential dilutions).
- FIG. 70 is a fragmentary top view of a reaction slide in which an
interconnecting conduit 380 is formed in the spacer. In the drawing, the left end ofconduit 380 communicates withreaction volume 66. The conduit extends to the right for transferring liquid fromreaction volume 66 to one or more additional reaction volumes disposed on thesame base 30. FIG. 71 schematically illustrates one use for such aninterconnecting conduit 380. - As schematically represented in FIG. 71, a reaction slide may comprise first and
second sample wells second reaction volumes sample wells third reaction volume 390 fed by two interconnectingconduits 380 which respectively communicate with thereaction volumes common base 30 and formed by a single appropriately-cut spacer.Elements - According to FIG. 71, two separate liquids may first be introduced into
reaction volumes respective sample wells volume 390 for further reaction or measurement or both. - For example, with
vents reaction volumes reaction volume 386 to fill with reagent from sample well 382 and to allow thereaction volume 388 to fill with reagent from 384. Thereafter, incubation or mixing or both occurs inreaction volumes vents channels 380 intoreaction volume 390. Thereaction volume 390 may have a volume equal to or less than the combined volumes of 386 and 388. Mixing may be carried out in 390, and a reaction therein may be monitored by any of the previously-described means for monitoring a reaction. If desired,reaction volumes - If desired, the two interconnecting
conduits 380 may be dimensioned such that they compensate for differences in viscosity between the liquids and the two reaction volumes. For example, if the liquid involume 386 is more viscous than that involume 388, and if it is desired to mix both liquids in equal proportions in 390, then theupper interconnecting conduit 380 in the drawing may be made wider than thelower interconnecting conduit 380 to produce substantially equivalent flow under capillary flow driving forces in the system. Light scatter sensors may be used to monitor the three reaction volumes to determine when the volumes are filled or empty, to determine how fast a volume is filling, and to operate controls to open and close the vents to start and stop the flow. - It will be understood that the same results may be accomplished using another means for achieving selective flow. For example, pinch valves may be incorporated both upstream and downstream of each of the
reaction volumes - FIG. 71 is a simple example of cascading, more complex examples of which will now be described.
- FIG. 72 shows four levels of cascading, which will be referred to as level I, level II, level III and level IV. Level I is represented by
reaction volumes Reaction volumes feed reaction volume 416 through interconnectingconduits 380. Similarly,reaction volumes feed reaction volume 418 through an additional set of interconnecting conduits. Selective flow is provided bypinch valve mechanisms 426.Reaction volumes reaction volumes reaction volume 424 represents level IV. If desired, additional reaction volumes may be provided as indicated by the dashed line extending to the left ofreaction volume 422 in the drawing. The size of the reaction volume at level IV is typically, but not necessarily, twice as great as the combined volumes of the reaction volumes at level III. Similarly, the combined volumes of the reaction volumes at level III are typically two times as great as those at level II. Each reaction volume may be empty or may contain a dry reagent. Any or all reaction volumes may be subjected to mixing by previously-described means and may be configured for liquid removal by a LAM. Any or all reaction volumes may be monitored by previously-described methods and also inspected by automated light microscope or by eye. - At level I, each of the liquids may be reacted and studied or monitored. A decision may be made thereafter to move any or all of the liquids to level II. Depending upon the nature of the decision made, further measurement may be made in
reaction volume - More specifically, if the contents of the sample wells400-406 are respectively representated as α, β, γ and Δ any or all of these liquids may be reacted at level I. Thereafter, at level II, α and β may be reacted together in
reaction volume 416. In the alternative, α may be sent alone to level II and reacted with dry bound reagent inreaction volume 416. The liquid may then be absorbed by a LAM to empty thereaction volume 416, after which time may be admitted toreaction volume 416 to further react with products captured by the bound reagent inreaction volume 416. Similar procedures and decisions may be made with regard to samples γ and Δ. - The resultant product in
reaction volume 416 may be sent toreaction volume 420, either alone or in admixture with a liquid fromreaction volume 418. The process then continues analogously untilreaction volume 424 is filled with liquid fromreaction volume 420 or from 422 or from both. - FIG. 73 schematically illustrates cascading in an order that is inverse from that shown in FIG. 72. In particular, a single initial sample placed in sample well428 and initially reacted in
reaction volume 430 may later be channeled to either or both ofdownstream reaction volumes - Yet a further example of cascading is shown schematically in FIG. 74, in which a plurality of sample wells and associated reaction volumes selectively feed a
single reaction volume 436, and the product of a reaction in thevolume 436 may, if desired, be further sent to yet additional reaction volumes, is illustrated by the interconnectingchannel 380 shown in phantom. Such additional reaction volumes may be disposed in serial, in parallel or cascaded. - In general, in regard to FIGS.70-73, it should be noted that the sizes of the sample wells and reaction volumes should be such as to provide a sufficient volume of liquid to fill whatever volumes are anticipated will be needed. For example, in FIG. 73, it may be necessary for the volume of sample well 428 to be sufficient to fill each of the illustrated reaction volumes. One means of providing such a sufficient volume of sample has been described above in the form of the enlarged sample well of FIG. 38.
- Thus, it may be seen that cascading of reaction volumes allows reactions to be initiated and monitored and, based upon the results obtained and decisions made (e.g., made by computer), cascading further allows for additional or subsequent reactions to be initiated, controlled and monitored using reaction products from the first reactions or samples from the first reactions. This provides the capability of performing complex assays with simple apparatus. It also allows a “tree assay” to be performed. That is, it allows for a series of branched assays to be performed in parallel fashion but connected via branch structure to a “tree” to answer a specific question. For example, the first reaction volume could answer the question: “acid or base?” The sample or reaction products could then be sent to one of two reaction volumes, one to perform further tests on “acids” and one to perform further tests on “bases”, and so forth. Ultimately, highly specific information may be known about the analyte.
- Another application might be in finding an antibody or antigen molecule which is specific for a given antigen or antibody. In this case, antibodies or antigens may be placed (or bound) in the reaction volumes, and the appearance of reactivity may be monitored and used as a basis for selecting other reactions. Similar applications could apply to DNA, DNA-probe reactions, enzyme-substrate reactions and so forth.
- Specific examples will now be given disclosing the use of various embodiments of a reaction slide according to the current invention. Other features of this invention will become apparent in the course of these exemplary embodiments which are given for illustration of the invention and are not intended to be limiting thereof.
- A 0.020 inch thick (3.0×0.75 inch) strip of polycarbonate was prewashed with distilled water and dried. Upon this strip or base was placed a two-layer spacer consisting of two pieces of a double-sided tape made from two thin sheets of unplasticized polyvinyl chloride, each sheet previously having been coated on both sides with medium-firm pressure sensitive acrylic adhesive. The two-layer overlay had previously been cut out in the center to create a sample well, conduit, reaction space, and vented area, as may be seen in FIG. 5. The double overlay composite plus adhesive coatings was of sufficient thickness to provide a final spacing between the base and cover of 0.007 inches. The cover was cut from 0.010 inch precleaned polycarbonate sheet and included a rectangular vent hole and a circular sample well hole. The cover was placed on top of the overlay and pressure applied by means of a small roller to join the overlay to the cover and base.
- The reaction volume was filled by means of a small syringe fitted with a 25 gauge needle and positioned so that the solution could flow from the edge of the sample well into the reaction volume. The solution in the syringe was a conventional rabbit brain thromboplastin emperically diluted to an appropriate concentration for use in manual or automated prothrombin time determinations. (Reagent calibration was previously checked by means of a standard manual prothrombin time test using control plasma.) The reaction slide was then frozen at −70° C. and freeze dried.
- A blood sample was collected by venipuncture using a 21 gauge needle. An evacuated tube containing sodium citrate, final concentration 3.8 mg/ml was used for collection. The first of two tubes was discarded, in accordance with NCCLS guidelines. The second tube was centrifuged in a conventional blood bank centrifuge (Clay Adams Sero-Fuge) and the plasma decanted. One drop of the plasma sample was placed in the sample well of the reaction slide (after the reaction slide was placed in light scattering measurement apparatus as shown in FIGS. 20 and 21 and prewarmed to 37° C. by means of a feedback controlled surface heater). The plasma sample immediately flowed into the reaction volume. The starting point, as monitored by the scatter detector, was clearly defined, and the endpoint was clearly discernable. This allowed the elapsed time to be readily measured and used to determine prothrombin time (as a percent of control plasma value).
- In this case, the light source was a high power light emitting diode (635 nm gallium arsenide/gallium phosphide) and the detector was a cadmium sulfide photoconductive cell. The photocell output was connected to a resistive bridge circuit and a chart recorder. Chart speed was 1 mm/sec, and gain was set at 1 volt full scale. Bridge voltage was 18 volts.
- A reaction slide was prepared as indicated in Example 1 except that it was fabricated using a single sheet of double sided tape as an overlay material (total thickness 0.0035 inches). The reaction slide was tested identically in the same instrument and provided a similar endpoint but with reduced signal intensity and longer lag phase (descending portion of the curve).
- A reaction slide prepared as indicated in Example 1 was placed in the monitoring instrument described in the previous example. A sample of citrated whole blood was added to the sample well. The resulting light scatter curve was observed to show an initial transient increase in scatter intensity, establishment of a new steady state level, and an eventual gradual rise from that level at the onset of a clot. Although the curve was different, the endpoint was similar but with reduced signal intensity. Elapsed time was equivalent to that observed for the plasma curve.
- A reaction slide prepared as indicated in Example 1 was placed in the monitoring instrument described in that example. Samples of citrated whole blood obtained from nine patients undergoing anticoagulant therapy (from a collaborataive study with Memorial Hospital, University of North Carolina, Chapel Hill) were centrifuged, and the plasma samples decanted and tested. A comparison was made of the values obtained with the light scatter instrument and reaction slide versus the clinical laboratory values obtained with a General Diagnostics Coag-A-Mate X-2 Automated Coagulation Analyzer. Although the actual elapsed time values are different for both instruments, an excellent correlation (0.95) was obtained. The endpoints were extremely sharp for the reaction slide values, and the clinical laboratory values could be calculated easily from the reaction slide values by using a conversion factor.
- A reaction slide prepared as indicated in Example 1 was placed in the monitoring instrument also described in Example 1. A finger stick was performed using an Autolet® Automatic Lancet (Ulster Scientific, Inc., Highland, N.Y.). One drop of blood was placed on the slide sample well. The blood was drawn immediately into the reaction space, initiating the reaction. The prothrombin time endpoint was discernable from the scatter curve in the form of a slope change. As in the case of the previous whole blood example (Example 3), the absolute magnitude of scatter was different (greater) for whole blood than for plasma. However, the elapsed time, and consequently the test result, was essentially the same.
- a) Reaction slides were fabricated employing spacers as described in Example 1, but with 3, 4, and 5 overlay layers to increase spacer thickness and conseqeuently chamber height of the reaction volume to 0.0105, 0.0140, and 0.0175 inches, respectively. It was observed that reaction slides with reaction volume heights of greater than 0.015 inches were not as reliable for retaining samples and aqueous reagents via capillary forces without leakage.
- b) It was similarly observed that reaction slides prepared as in Example 1 with spacers less than 0.0015 inches thick tended to be difficult to fill and empty of liquid.
- c) A reaction slide prepared as in Example 1 but with cyanoacrylate adhesive and a 0.002 inch thick polyethylene terephthalate sheet did not work well. (Two cyanoacrylate preparations were tried: Wonder-Bond Plus, Borden, Inc., Columbus Ohio and Pacer Tech Advanced Technology Series ATS-HC5, Pacer Technology & Resources, Campbell, Calif.). Waveguide properties were hampered by inhomogeneities in the adhesive, and
Claims (25)
1. An element for performing a liquid assay, said element comprising therein a channel structure defining a sample well and a reaction volume in communication with each other, said channel structure having a geometry causing a liquid sample placed in the said sample well to be drawn into and filling the said reaction volume via capillary action, wherein after the said reaction volume is filled the said liquid sample remains stationary therein.
2. The element of claim 1 , said element comprising a means for monitoring a reaction in the said reaction volume.
3. The element of claim 1 , said element comprising a means for channelling light from an outside source to the said reaction volume.
4. The element of claim 1 , said element comprising a means for detecting light emitted from the said reaction volume.
5. The element of claim 4 , wherein the said means for detecting light comprises a means for detecting scattered light emitted from the said reaction volume.
6. The element of claim 4 , wherein the said means for detecting light comprises a means for detecting reflected light emitted from the said reaction volume.
7. The element of claim 2 , said element being disposed in close proximity to a permanent magnet and an electromagnet, wherein the said permanent magnet is situated between the said electromagnet and the said element.
8. The element of claim 1 , said element comprising:
a base comprising a major surface, an overlay on said base, and a cover situated on said overlay, opposite said base;
said overlay comprising therein a channel structure defining a sample well and a reaction space in communication with the said sample well;
said cover comprising therein a means for adding a sample to be analyzed to the said sample well;
a means for channelling light from an outside source to the reaction chamber; and
a means for detecting light emitted from the said reaction chamber.
9. The element of claim 8 , said element comprising a vent, and a conduit in communication with both the said sample well and the said reaction space.
10. The element of claim 1 , said element comprising a liquid absorbing matrix for withdrawing fluid from the said reaction volume.
11. The element of claim 2 , wherein the said means for monitoring a reaction in the said reaction volume employs light and wherein at least some of the external surfaces of the reaction slide not used for transmission of light to the reaction volume or for detection of light emitted from the said reaction volume are opaque to light.
12. The element of claim 3 , wherein the said means for channelling light from an outside source to the said reaction volume comprises an optical fiber assembly.
13. The element of claim 8 , said element comprising a cover having a length which is less than the length of the said overlay and less than the length of the said base, said element comprising an end cover coplanar with the said cover and spaced therefrom.
14. The element of claim 8 , wherein the distal end of the said overlay is open so that the said reaction space vents longitudinally between the said cover and the said base.
15. The element of claim 14 , said element comprising a liquid absorbing matrix fixed to the said base and overhanging the said distal end of the said cover.
16. The element of claim 8 , wherein the distal end of the said overlay is open so that the said reaction space vents longitudinally between the said cover and the said base; said overlay being provided with a first conduit communicating the said sample well with the said reaction volume, and a second conduit extending backward to a point beyond the sample well wherein the end portion of the said second conduit is a means for determining that proper filling of the said reaction volume with a fluid has been achieved.
17. The element of claim 8 , wherein the said cover comprises a major planar segment having lateral sides bent downwardly to form walls and then laterally to form tabs, said tabs being bound to the said base.
18. The element of claim 1 , wherein the internal surfaces of the said element have been treated to increase their hydrophilicity.
19. The element of claim 8 , wherein the said spacer has a thickness of from 0.001 to 0.02 inches.
20. The element of claim 16 , wherein the said spacer has a thickness of from 0.002 to 0.008 inches.
21. A method for performing an assay, comprising:
adding a sample to the sample well of an element comprising a channel structure defining a sample well and a reaction volume in communication with each other, wherein the said element contains a measured amount of at least one reagent situated in the said reaction volume; wherein a specific volume of the said biological sample is awn into the said reaction volume by capillary anion and contacts the said reagent to initiate a reaction between the said sample and the said reagent, and
monitoring said reaction.
22. The method of claim 21 , wherein the said assay is the assay of biological sample.
23. The method of claim 22 , comprising monitoring the said reaction by radiating light into the said reaction volume and monitoring scattering of the light in the said reaction volume.
24. The method of claim 21 , comprising:
using an element containing inert magnetic particles within the said reaction volume in association with a permanent magnet and a electromagnet disposed in close proximity to the said element and wherein the said permanent magnet is situated between the said electromagnet;
applying cycles of energy to the said electromagnet to causes a change in orientation of the said inert magnetic particles; and
monitoring the said change in orientation of the said inert magnetic particle to monitor the said reaction.
25. An assembly Comprising at least two of the elements of claim 1 in communication with each other.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/091,296 US20020119486A1 (en) | 1987-04-03 | 2002-03-06 | Element and method for performing biological assays accurately, rapidly and simply |
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/033,817 US4849340A (en) | 1987-04-03 | 1987-04-03 | Reaction system element and method for performing prothrombin time assay |
US35085189A | 1989-05-12 | 1989-05-12 | |
US86563492A | 1992-04-09 | 1992-04-09 | |
US08/247,411 US5658723A (en) | 1987-04-03 | 1994-05-23 | Immunoassay system using forced convection currents |
US08/819,341 US6197494B1 (en) | 1987-04-03 | 1997-03-18 | Apparatus for performing assays on liquid samples accurately, rapidly and simply |
US48203600A | 2000-01-13 | 2000-01-13 | |
US10/091,296 US20020119486A1 (en) | 1987-04-03 | 2002-03-06 | Element and method for performing biological assays accurately, rapidly and simply |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US48203600A Continuation | 1987-04-03 | 2000-01-13 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US29/167,714 Division USD501678S1 (en) | 1987-04-03 | 2002-09-20 | Assay card for an assay chamber |
Publications (1)
Publication Number | Publication Date |
---|---|
US20020119486A1 true US20020119486A1 (en) | 2002-08-29 |
Family
ID=21872614
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US07/033,817 Expired - Lifetime US4849340A (en) | 1987-04-03 | 1987-04-03 | Reaction system element and method for performing prothrombin time assay |
US08/247,411 Expired - Lifetime US5658723A (en) | 1987-04-03 | 1994-05-23 | Immunoassay system using forced convection currents |
US08/819,341 Expired - Fee Related US6197494B1 (en) | 1987-04-03 | 1997-03-18 | Apparatus for performing assays on liquid samples accurately, rapidly and simply |
US10/091,296 Abandoned US20020119486A1 (en) | 1987-04-03 | 2002-03-06 | Element and method for performing biological assays accurately, rapidly and simply |
Family Applications Before (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US07/033,817 Expired - Lifetime US4849340A (en) | 1987-04-03 | 1987-04-03 | Reaction system element and method for performing prothrombin time assay |
US08/247,411 Expired - Lifetime US5658723A (en) | 1987-04-03 | 1994-05-23 | Immunoassay system using forced convection currents |
US08/819,341 Expired - Fee Related US6197494B1 (en) | 1987-04-03 | 1997-03-18 | Apparatus for performing assays on liquid samples accurately, rapidly and simply |
Country Status (8)
Country | Link |
---|---|
US (4) | US4849340A (en) |
EP (1) | EP0308494B1 (en) |
JP (1) | JP2736091B2 (en) |
AT (1) | ATE120543T1 (en) |
AU (1) | AU613623B2 (en) |
CA (1) | CA1310566C (en) |
DE (1) | DE3853457T2 (en) |
WO (1) | WO1988007666A1 (en) |
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050015000A1 (en) * | 2003-06-06 | 2005-01-20 | Nasr-Eddine Djennati | Method and device for analysing a liquid |
US7053783B2 (en) | 2002-12-18 | 2006-05-30 | Biovigilant Systems, Inc. | Pathogen detector system and method |
EP1666136A1 (en) * | 2003-07-24 | 2006-06-07 | AOGAKI, Ryoichi | Microreactor including magnetic barrier |
US20060134387A1 (en) * | 2004-12-20 | 2006-06-22 | William Gottermeier | Multilayer article formed by adhesive ablation |
US20070013910A1 (en) * | 2004-07-30 | 2007-01-18 | Jian-Ping Jiang | Pathogen and particle detector system and method |
US20080081341A1 (en) * | 2006-10-03 | 2008-04-03 | Jonathan Scott Maher | Immunoassay test device and method of use |
US20090242799A1 (en) * | 2007-12-03 | 2009-10-01 | Bolotin Charles E | Method for the detection of biologic particle contamination |
WO2010022019A1 (en) * | 2008-08-21 | 2010-02-25 | Siemens Healthcare Diagnostics Inc. | Multi-layer slides for analysis of urine sediments |
US20100108910A1 (en) * | 2005-07-15 | 2010-05-06 | Michael Morrell | Pathogen and particle detector system and method |
WO2010052307A3 (en) * | 2008-11-07 | 2010-07-22 | Roche Diagnostics Gmbh | Test element for detecting an analyte in a sample |
WO2010122158A1 (en) * | 2009-04-23 | 2010-10-28 | Dublin City University | A lateral flow assay device for coagulation monitoring and method thereof |
WO2012045753A1 (en) * | 2010-10-07 | 2012-04-12 | Boehringer Ingelheim Microparts Gmbh | Microfluidic platform |
CN102985804A (en) * | 2010-07-09 | 2013-03-20 | 皇家飞利浦电子股份有限公司 | Cartridge with large-scale manufacturing design |
CN105074465A (en) * | 2013-02-22 | 2015-11-18 | 株式会社日立高新技术 | Biological analyzing device and biomolecule analyzing equipment |
EP2726852B1 (en) * | 2011-06-30 | 2020-11-25 | Koninklijke Philips N.V. | Multiple examinations of a sample |
WO2021216764A1 (en) * | 2020-04-24 | 2021-10-28 | Leavitt Medical, Inc. D/B/A Lumea | Focal plane spacers for microscope slides and related systems and methods |
Families Citing this family (353)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5144139A (en) * | 1985-08-05 | 1992-09-01 | Biotrack, Inc. | Capillary flow device |
US5164598A (en) * | 1985-08-05 | 1992-11-17 | Biotrack | Capillary flow device |
US5204525A (en) * | 1985-08-05 | 1993-04-20 | Biotrack | Capillary flow device |
US5140161A (en) * | 1985-08-05 | 1992-08-18 | Biotrack | Capillary flow device |
US4935346A (en) | 1986-08-13 | 1990-06-19 | Lifescan, Inc. | Minimum procedure system for the determination of analytes |
US4918025A (en) * | 1987-03-03 | 1990-04-17 | Pb Diagnostic Systems, Inc. | Self contained immunoassay element |
US5110727A (en) * | 1987-04-03 | 1992-05-05 | Cardiovascular Diagnostics, Inc. | Method for performing coagulation assays accurately, rapidly and simply, using dry chemical reagents and paramagnetic particles |
US4849340A (en) * | 1987-04-03 | 1989-07-18 | Cardiovascular Diagnostics, Inc. | Reaction system element and method for performing prothrombin time assay |
US5209904A (en) * | 1987-12-23 | 1993-05-11 | Abbott Laboratories | Agglutination reaction device utilizing selectively impregnated porous material |
US5779976A (en) * | 1988-11-03 | 1998-07-14 | Igen International, Inc. | Apparatus for improved luminescence assays |
US5114350A (en) * | 1989-03-08 | 1992-05-19 | Cholestech Corporation | Controlled-volume assay apparatus |
US4957582A (en) * | 1989-03-16 | 1990-09-18 | Eastman Kodak Company | Capillary transport zone coated with adhesive |
IE940110L (en) * | 1989-03-23 | 1990-09-23 | Bunce Roger A | Liquid transfer devices |
US5039617A (en) * | 1989-04-20 | 1991-08-13 | Biotrack, Inc. | Capillary flow device and method for measuring activated partial thromboplastin time |
EP0397424A3 (en) * | 1989-05-08 | 1991-08-21 | Biotrack, Inc. | Multiple analysis system |
US5147609A (en) * | 1989-05-19 | 1992-09-15 | Pb Diagnostic Systems, Inc. | Assay element |
IT1230744B (en) * | 1989-07-07 | 1991-10-29 | Instrumentation Lab Spa | METHOD FOR DETERMINING THE FUNCTIONAL ACTIVITY OF PROTEIN S IN HUMAN PLASMA. |
JPH0810193B2 (en) * | 1989-08-21 | 1996-01-31 | 富士写真フイルム株式会社 | A method for determining spotting abnormality in a biochemical analysis method |
US5622870A (en) * | 1989-11-27 | 1997-04-22 | Behringwerke Ag | Device and method for completing a fluidic circuit |
US5104812A (en) * | 1989-11-27 | 1992-04-14 | Syntex (U.S.A.) Inc. | Device and method for interrupting capillary flow |
US5068181A (en) * | 1989-12-01 | 1991-11-26 | Akzo N.V. | Method of monitoring reagent delivery in a scanning spectrophotometer |
US5646046A (en) * | 1989-12-01 | 1997-07-08 | Akzo Nobel N.V. | Method and instrument for automatically performing analysis relating to thrombosis and hemostasis |
US5110724A (en) * | 1990-04-02 | 1992-05-05 | Cholestech Corporation | Multi-analyte assay device |
US4986964A (en) * | 1990-04-19 | 1991-01-22 | Center For Innovative Technology | Clot retractometer |
WO1991018276A1 (en) * | 1990-05-22 | 1991-11-28 | Kelly Kenneth A | Microassay strip device for immunoassay |
TW221493B (en) * | 1990-07-10 | 1994-03-01 | Cardiovascular Diagnostics Inc | |
WO1992005440A1 (en) * | 1990-09-26 | 1992-04-02 | Akers Research Corporation | Improved ligand assay |
ZA92803B (en) | 1991-02-06 | 1992-11-25 | Igen Inc | Method and apparatus for magnetic microparticulate based luminescene asay including plurality of magnets |
EP0501796A3 (en) * | 1991-03-01 | 1993-10-06 | Biotrack, Inc. | Capillary stop-flow junction having improved stability against accidental fluid flow |
US5207984A (en) * | 1991-03-11 | 1993-05-04 | Miles Inc. | Blood sample collection and test device |
US6168956B1 (en) | 1991-05-29 | 2001-01-02 | Beckman Coulter, Inc. | Multiple component chromatographic assay device |
US5877028A (en) | 1991-05-29 | 1999-03-02 | Smithkline Diagnostics, Inc. | Immunochromatographic assay device |
US5998220A (en) | 1991-05-29 | 1999-12-07 | Beckman Coulter, Inc. | Opposable-element assay devices, kits, and methods employing them |
AR244884A1 (en) * | 1991-06-25 | 1993-11-30 | Saliva Diagnostic Systems Inc | Sampling device and sample adequacy system |
US5540888A (en) * | 1991-11-11 | 1996-07-30 | British Technology Group Limited | Liquid transfer assay devices |
JP3382632B2 (en) * | 1992-03-13 | 2003-03-04 | オリンパス光学工業株式会社 | Method for measuring biological substance and reaction vessel used for the method |
US5443959A (en) * | 1992-09-09 | 1995-08-22 | Tokuyama Corporation | Method of assaying fibrinogen, dry reagent therefor, and process for the preparation thereof |
US5344754A (en) * | 1993-01-13 | 1994-09-06 | Avocet Medical, Inc. | Assay timed by electrical resistance change and test strip |
JPH08507148A (en) * | 1993-02-17 | 1996-07-30 | カーディオヴァスキュラー ダイアグノスティクス,インク. | Solid-phase chemical cascade immunoassay and affinity assay |
US5512492A (en) * | 1993-05-18 | 1996-04-30 | University Of Utah Research Foundation | Waveguide immunosensor with coating chemistry providing enhanced sensitivity |
US5670329A (en) * | 1993-05-28 | 1997-09-23 | Cardiovascular Diagnostics, Inc. | Method and analytical system for performing fibrinogen assays accurately, rapidly and simply using a rotating magnetic field |
US6521187B1 (en) | 1996-05-31 | 2003-02-18 | Packard Instrument Company | Dispensing liquid drops onto porous brittle substrates |
US6537817B1 (en) | 1993-05-31 | 2003-03-25 | Packard Instrument Company | Piezoelectric-drop-on-demand technology |
US6203759B1 (en) | 1996-05-31 | 2001-03-20 | Packard Instrument Company | Microvolume liquid handling system |
DE4323672A1 (en) * | 1993-07-15 | 1995-01-19 | Boehringer Mannheim Gmbh | Device for the simultaneous determination of analytes |
US5841023A (en) * | 1993-08-31 | 1998-11-24 | Boehringer Mannheim Corporation | Magnet for medical instrument |
US5526111A (en) * | 1993-08-31 | 1996-06-11 | Boehringer Mannheim Corporation | Method and apparatus for calculating a coagulation characteristic of a sample of blood a blood fraction or a control |
EP0775311B1 (en) * | 1993-08-31 | 2002-07-03 | Roche Diagnostics Corporation | Analog heater control for medical instrument |
US5522255A (en) | 1993-08-31 | 1996-06-04 | Boehringer Mannheim Corporation | Fluid dose, flow and coagulation sensor for medical instrument |
WO1995007050A2 (en) * | 1993-08-31 | 1995-03-16 | Boehringer Mannheim Corporation | Power supply control for medical instrument |
JP3470973B2 (en) * | 1993-08-31 | 2003-11-25 | ロシュ ダイアグノスティックス コーポレーション | Reagents and their use |
US5478751A (en) * | 1993-12-29 | 1995-12-26 | Abbott Laboratories | Self-venting immunodiagnositic devices and methods of performing assays |
EP0772484B1 (en) * | 1994-07-28 | 2008-02-27 | Pall Corporation | Fibrous web and process of preparing same |
US5582907A (en) * | 1994-07-28 | 1996-12-10 | Pall Corporation | Melt-blown fibrous web |
GB9416002D0 (en) * | 1994-08-08 | 1994-09-28 | Univ Cranfield | Fluid transport device |
US5504011A (en) * | 1994-10-21 | 1996-04-02 | International Technidyne Corporation | Portable test apparatus and associated method of performing a blood coagulation test |
JP3388060B2 (en) * | 1994-11-25 | 2003-03-17 | 日本碍子株式会社 | Fluid characteristic measuring element and fluid characteristic measuring device |
AU689143B2 (en) * | 1994-12-02 | 1998-03-26 | Cardiovascular Diagnostics, Inc. | Improved method and analytical system for performing fibrinogen assays accurately, rapidly and simply |
US5508521A (en) * | 1994-12-05 | 1996-04-16 | Cardiovascular Diagnostics Inc. | Method and apparatus for detecting liquid presence on a reflecting surface using modulated light |
US5814565A (en) * | 1995-02-23 | 1998-09-29 | University Of Utah Research Foundation | Integrated optic waveguide immunosensor |
DE19512710A1 (en) * | 1995-04-10 | 1996-10-17 | Behringwerke Ag | Biosensor |
DE19523061A1 (en) * | 1995-06-24 | 1997-01-02 | Boehringer Mannheim Gmbh | Element and system for collecting, transporting and storing sample material to be analyzed |
US20020022261A1 (en) * | 1995-06-29 | 2002-02-21 | Anderson Rolfe C. | Miniaturized genetic analysis systems and methods |
US5863502A (en) * | 1996-01-24 | 1999-01-26 | Sarnoff Corporation | Parallel reaction cassette and associated devices |
US6541213B1 (en) * | 1996-03-29 | 2003-04-01 | University Of Washington | Microscale diffusion immunoassay |
US20020090644A1 (en) * | 1999-05-21 | 2002-07-11 | Weigl Bernhard H. | Microscale diffusion immunoassay |
US5942443A (en) * | 1996-06-28 | 1999-08-24 | Caliper Technologies Corporation | High throughput screening assay systems in microscale fluidic devices |
CA2256572C (en) * | 1996-06-14 | 2008-08-05 | Minnesota Mining And Manufacturing Company | Display unit and methods of displaying an image |
US20060000722A1 (en) * | 1996-06-28 | 2006-01-05 | Caliper Life Sciences, Inc. | High throughput screening assay systems in microscale fluidic devices |
NZ333346A (en) * | 1996-06-28 | 2000-03-27 | Caliper Techn Corp | High-throughput screening assay systems in microscale fluidic devices |
US5945345A (en) * | 1996-08-27 | 1999-08-31 | Metrika, Inc. | Device for preventing assay interference using silver or lead to remove the interferant |
US5832165A (en) | 1996-08-28 | 1998-11-03 | University Of Utah Research Foundation | Composite waveguide for solid phase binding assays |
US6043878A (en) * | 1996-09-24 | 2000-03-28 | Case Western Reserve University | Device for optical and electrochemical measurements in microliter size samples |
US7153651B1 (en) * | 1996-10-31 | 2006-12-26 | Inverness Medical - Biostar, Inc. | Flow-through optical assay devices providing laminar flow of fluid samples, and methods of construction thereof |
US6703247B1 (en) | 1996-12-23 | 2004-03-09 | American Registry Of Pathology | Apparatus and methods for efficient processing of biological samples on slides |
US8293064B2 (en) * | 1998-03-02 | 2012-10-23 | Cepheid | Method for fabricating a reaction vessel |
AU6343398A (en) * | 1997-02-28 | 1998-09-18 | Cepheid | Heat exchanging, optically interrogated chemical reaction assembly |
WO1998039643A1 (en) * | 1997-03-05 | 1998-09-11 | Diametrics | Method and apparatus for measurement of whole blood coagulation parameters |
US6052224A (en) * | 1997-03-21 | 2000-04-18 | Northern Edge Associates | Microscope slide system and method of use |
US5910288A (en) * | 1997-07-10 | 1999-06-08 | Hewlett-Packard Company | Method and apparatus for mixing a thin film of fluid |
US6066243A (en) * | 1997-07-22 | 2000-05-23 | Diametrics Medical, Inc. | Portable immediate response medical analyzer having multiple testing modules |
US6061128A (en) * | 1997-09-04 | 2000-05-09 | Avocet Medical, Inc. | Verification device for optical clinical assay systems |
US6222619B1 (en) * | 1997-09-18 | 2001-04-24 | University Of Utah Research Foundation | Diagnostic device and method |
JP2001518624A (en) * | 1997-09-26 | 2001-10-16 | ユニバーシティ・オブ・ワシントン | Simultaneous particle separation and chemical reactions |
DE19753849A1 (en) * | 1997-12-04 | 1999-06-10 | Roche Diagnostics Gmbh | Analytical test element with a tapered capillary channel |
US5908786A (en) * | 1997-12-12 | 1999-06-01 | Akzo Nobel, N.V. | Blood coagulation monitoring device with liquid crystal and gradient heater |
SE520341C2 (en) | 1998-01-14 | 2003-06-24 | Hemocue Ab | Method and procedure for mixing in a thin liquid state |
SE9800070D0 (en) | 1998-01-14 | 1998-01-14 | Hemocue Ab | mixing method |
US5975153A (en) * | 1998-02-13 | 1999-11-02 | Roche Diagnostics Corporation | Capillary fill test device with improved fluid delivery |
SE9800590D0 (en) * | 1998-02-26 | 1998-02-26 | Global Hemostasis Inst Mgr Ab | Determination of polymerization / coagulation in a fluid |
US6200531B1 (en) * | 1998-05-11 | 2001-03-13 | Igen International, Inc. | Apparatus for carrying out electrochemiluminescence test measurements |
US6312888B1 (en) | 1998-06-10 | 2001-11-06 | Abbott Laboratories | Diagnostic assay for a sample of biological fluid |
US6165795A (en) * | 1998-06-25 | 2000-12-26 | Cardiovascular Diagnostics, Inc. | Methods for performing fibrinogen assays using dry chemical reagents containing ecarin and magnetic particles |
US6830934B1 (en) * | 1999-06-15 | 2004-12-14 | Lifescan, Inc. | Microdroplet dispensing for a medical diagnostic device |
US6521182B1 (en) * | 1998-07-20 | 2003-02-18 | Lifescan, Inc. | Fluidic device for medical diagnostics |
US6084660A (en) * | 1998-07-20 | 2000-07-04 | Lifescan, Inc. | Initiation of an analytical measurement in blood |
US6132685A (en) * | 1998-08-10 | 2000-10-17 | Caliper Technologies Corporation | High throughput microfluidic systems and methods |
US6186659B1 (en) | 1998-08-21 | 2001-02-13 | Agilent Technologies Inc. | Apparatus and method for mixing a film of fluid |
US6482306B1 (en) | 1998-09-22 | 2002-11-19 | University Of Washington | Meso- and microfluidic continuous flow and stopped flow electroösmotic mixer |
US6498497B1 (en) * | 1998-10-14 | 2002-12-24 | Caliper Technologies Corp. | Microfluidic controller and detector system with self-calibration |
US20060216744A1 (en) * | 1998-12-23 | 2006-09-28 | American Registry Of Pathology Armed Forces Institute Of Pathology | Apparatus and methods for efficient processing of biological samples on slides |
CA2356354A1 (en) * | 1998-12-23 | 2000-07-06 | American Registry Of Pathology | Apparatus and methods for efficient processing of biological samples on slides |
FR2792333B1 (en) * | 1999-04-14 | 2003-01-24 | Labonord | DEVICE FOR DEPOSITING CELLS ON AN ANALYSIS PLATE |
US20020019062A1 (en) * | 1999-06-18 | 2002-02-14 | Peter Lea | Assay devices |
US6258593B1 (en) * | 1999-06-30 | 2001-07-10 | Agilent Technologies Inc. | Apparatus for conducting chemical or biochemical reactions on a solid surface within an enclosed chamber |
US6645359B1 (en) * | 2000-10-06 | 2003-11-11 | Roche Diagnostics Corporation | Biosensor |
WO2001026813A2 (en) | 1999-10-08 | 2001-04-19 | Micronics, Inc. | Microfluidics without electrically of mechanically operated pumps |
US6136549A (en) * | 1999-10-15 | 2000-10-24 | Feistel; Christopher C. | systems and methods for performing magnetic chromatography assays |
US6319719B1 (en) | 1999-10-28 | 2001-11-20 | Roche Diagnostics Corporation | Capillary hematocrit separation structure and method |
US6629057B2 (en) | 1999-11-05 | 2003-09-30 | Beckman Coulter, Inc. | Comprehensive verification systems and methods for analyzer-read clinical assays |
US6338969B1 (en) * | 1999-11-15 | 2002-01-15 | Bayer Corporation | Assay test system for regulating temperature |
US6458326B1 (en) | 1999-11-24 | 2002-10-01 | Home Diagnostics, Inc. | Protective test strip platform |
JP2001159618A (en) * | 1999-12-03 | 2001-06-12 | Matsushita Electric Ind Co Ltd | Biosensor |
BR0016711A (en) | 1999-12-24 | 2002-09-03 | Roche Diagnostics Gmbh | Test Element Analysis System |
FR2803225B1 (en) * | 1999-12-29 | 2002-06-14 | Biomerieux Sa | ANALYZING APPARATUS WITH VARIABLE GEOMETRY REACTIONAL COMPARTMENT, LIQUID MIXING AND GUIDING METHOD |
US6562210B1 (en) * | 1999-12-30 | 2003-05-13 | Roche Diagnostics Corporation | Cell for electrochemical anaylsis of a sample |
DE10002500A1 (en) * | 2000-01-21 | 2001-07-26 | Univ Albert Ludwigs Freiburg | Capillary action mixer for mixing components which are analyzed during reaction, e.g. in DNA sequencing, uses capillary action to feed the reactants into the mixer |
US6406672B1 (en) | 2000-01-28 | 2002-06-18 | Roche Diagnostics | Plasma retention structure providing internal flow |
US6451264B1 (en) * | 2000-01-28 | 2002-09-17 | Roche Diagnostics Corporation | Fluid flow control in curved capillary channels |
DE10005203A1 (en) * | 2000-02-05 | 2001-08-16 | Bayerische Motoren Werke Ag | Measurement arrangement for forming and recording image of 3-dimensional object derives measurement head unit position relative to object from distances between measurement points |
US6323040B1 (en) * | 2000-02-15 | 2001-11-27 | Ryan S. Raz | System for biological specimen preparation |
US6402704B1 (en) * | 2000-04-18 | 2002-06-11 | Sonexxus Incorporated | Prothrombin test apparatus for home use |
AU2001261020A1 (en) * | 2000-05-09 | 2001-11-20 | Pharmanetics Incorporated | Platelet function assay and reagent therefor |
WO2001089691A2 (en) * | 2000-05-24 | 2001-11-29 | Micronics, Inc. | Capillaries for fluid movement within microfluidic channels |
AU7197501A (en) * | 2000-07-31 | 2002-02-13 | Lifescan Inc | Method and apparatus for detecting the presence of a fluid on a test strip |
AU2000280282A1 (en) * | 2000-10-17 | 2002-04-29 | Abbott Laboratories | Diagnostic assay for a sample of biological fluid |
GB0028647D0 (en) * | 2000-11-24 | 2001-01-10 | Nextgen Sciences Ltd | Apparatus for chemical assays |
US7144495B2 (en) * | 2000-12-13 | 2006-12-05 | Lifescan, Inc. | Electrochemical test strip with an integrated micro-needle and associated methods |
US6620310B1 (en) * | 2000-12-13 | 2003-09-16 | Lifescan, Inc. | Electrochemical coagulation assay and device |
EP1226863B1 (en) * | 2000-12-28 | 2004-11-03 | F.Hoffmann-La Roche Ag | Method for processing a nucleic acid sample by swinging a segment of a cartridge wall, a system and a cartridge for performing such a method |
DE10101576B4 (en) * | 2001-01-15 | 2016-02-18 | Presens Precision Sensing Gmbh | Optical sensor and sensor field |
US6541266B2 (en) | 2001-02-28 | 2003-04-01 | Home Diagnostics, Inc. | Method for determining concentration of an analyte in a test strip |
US6562625B2 (en) | 2001-02-28 | 2003-05-13 | Home Diagnostics, Inc. | Distinguishing test types through spectral analysis |
US6525330B2 (en) | 2001-02-28 | 2003-02-25 | Home Diagnostics, Inc. | Method of strip insertion detection |
WO2002072264A1 (en) * | 2001-03-09 | 2002-09-19 | Biomicro Systems, Inc. | Method and system for microfluidic interfacing to arrays |
US7867756B2 (en) * | 2001-04-12 | 2011-01-11 | Arkray, Inc. | Specimen analyzing implement |
US6759009B2 (en) * | 2001-05-04 | 2004-07-06 | Portascience Incorporated | Method and device for clotting time assay |
US20030211551A1 (en) * | 2001-05-09 | 2003-11-13 | Mahan Donald E | Platelet function assay and reagent therefor |
EP1393072A1 (en) * | 2001-05-17 | 2004-03-03 | Bayer Healthcare LLC | Assay test system for regulating temperature |
US7473398B2 (en) | 2001-05-25 | 2009-01-06 | Roche Diagnostics Operations, Inc. | Biosensor |
AU2002330855A1 (en) * | 2001-06-12 | 2002-12-23 | Pelikan Technologies, Inc. | Thermal sensor for fluid detection |
US7402282B2 (en) | 2001-07-20 | 2008-07-22 | Ortho-Clinical Diagnostics, Inc. | Auxiliary sample supply for a clinical analyzer |
EP2290358B1 (en) * | 2001-07-27 | 2015-11-11 | ARKRAY, Inc. | Analyzing instrument |
US6678542B2 (en) * | 2001-08-16 | 2004-01-13 | Optiscan Biomedical Corp. | Calibrator configured for use with noninvasive analyte-concentration monitor and employing traditional measurements |
DE10140699A1 (en) * | 2001-08-24 | 2003-03-13 | Roche Diagnostics Gmbh | Arrangement and method for examining the flowability of a physiological liquid sample |
US6902904B2 (en) | 2001-08-27 | 2005-06-07 | Pharmanetics Incorporated | Coagulation assay reagents containing lanthanides |
FR2829576B1 (en) * | 2001-09-12 | 2003-10-31 | Bio Merieux | METHOD AND DEVICE FOR ISOLATING AND / OR DETERMINING AN ANALYTE |
JP2005504317A (en) | 2001-09-28 | 2005-02-10 | イビディ ゲムベーハー | Flow chamber |
DE10148210B4 (en) * | 2001-09-28 | 2005-09-15 | Ibidi Gmbh | flow chamber |
DE10151778A1 (en) * | 2001-10-19 | 2003-05-08 | Philips Corp Intellectual Pty | Method for determining the spatial distribution of magnetic particles |
US6989891B2 (en) * | 2001-11-08 | 2006-01-24 | Optiscan Biomedical Corporation | Device and method for in vitro determination of analyte concentrations within body fluids |
US7050157B2 (en) * | 2001-11-08 | 2006-05-23 | Optiscan Biomedical Corp. | Reagent-less whole-blood glucose meter |
US6680177B2 (en) | 2001-12-07 | 2004-01-20 | Cardiovascular Diagnostics, Inc. | Low molecular weight heparin assay, system and reagent therefor |
DE60225593T2 (en) * | 2001-12-21 | 2009-04-16 | Ge Healthcare Bio-Sciences Ab | IMMOBILIZATION OF BINDING MATERIALS |
WO2003062791A2 (en) | 2002-01-18 | 2003-07-31 | University Of Utah Research Foundation | Detection of single nucleotide polymorphisms using planar waveguides |
US7004928B2 (en) | 2002-02-08 | 2006-02-28 | Rosedale Medical, Inc. | Autonomous, ambulatory analyte monitor or drug delivery device |
JP3892743B2 (en) * | 2002-03-01 | 2007-03-14 | 日本碍子株式会社 | Reaction cell and method of use thereof |
US20060134713A1 (en) | 2002-03-21 | 2006-06-22 | Lifescan, Inc. | Biosensor apparatus and methods of use |
EP1495334A4 (en) * | 2002-03-25 | 2008-10-08 | Farallon Medical Inc | System for performing blood coagulation assays and measuring blood clotting times |
US7524462B2 (en) * | 2002-03-29 | 2009-04-28 | Agilent Technologies, Inc. | Capillary flow for a heterogenous assay in a micro-channel environment |
ES2252358T3 (en) * | 2002-04-09 | 2006-05-16 | Cholestech Corporation | METHOD AND TEST DEVICE FOR THE QUANTIFICATION OF CHOLESTEROL ASSOCIATED WITH HIGH DENSITY LIPOPROTEINS. |
AU2003228581A1 (en) * | 2002-04-17 | 2003-11-03 | Biosafe Medical Technologies, Inc. | Method and device for measurement of hematocrit |
DE10219154A1 (en) * | 2002-04-29 | 2003-11-20 | Siemens Ag | Procedure for monitoring the availability of connections in MPLS networks |
AU2003235970A1 (en) * | 2002-04-30 | 2003-11-17 | Arkray, Inc. | Analysis instrument, sample analysis method and analysis device using the instrument, and method of forming opening in the instrument |
AU2003235968A1 (en) * | 2002-04-30 | 2003-11-17 | Arkray, Inc. | Analytical instrument |
US7285425B2 (en) * | 2002-05-14 | 2007-10-23 | Siemens Medical Solutions Diagnostics | Assay test system for regulating temperature |
US6958132B2 (en) * | 2002-05-31 | 2005-10-25 | The Regents Of The University Of California | Systems and methods for optical actuation of microfluidics based on opto-electrowetting |
US7919308B2 (en) * | 2002-06-14 | 2011-04-05 | Agilent Technologies, Inc. | Form in place gaskets for assays |
AUPS309002A0 (en) | 2002-06-20 | 2002-07-11 | Vision Biosystems Limited | A covertile for a substrate |
US7553448B2 (en) * | 2002-06-20 | 2009-06-30 | Bioveris Corporation | Electrochemiluminescence flow cell and flow cell components |
US6939450B2 (en) * | 2002-10-08 | 2005-09-06 | Abbott Laboratories | Device having a flow channel |
JP3746756B2 (en) * | 2002-10-22 | 2006-02-15 | 株式会社日立製作所 | Solution stirring device, solution stirring method |
US7126676B2 (en) * | 2002-11-07 | 2006-10-24 | Frank Anthony Greco | Spectral analysis of light scattered from clotting blood |
US20060110283A1 (en) * | 2002-11-12 | 2006-05-25 | Inverness Medical Switzerland Gmbh | Photometric determination of coagulation time in undiluted whole blood |
EP1419818B1 (en) * | 2002-11-14 | 2013-10-30 | Boehringer Ingelheim microParts GmbH | Device for sequential transport of liquids by capillary forces |
US20040101439A1 (en) * | 2002-11-21 | 2004-05-27 | Fusco Adam J | Biological and chemical reaction devices and methods of manufacture |
US20040132168A1 (en) * | 2003-01-06 | 2004-07-08 | Peter Rule | Sample element for reagentless whole blood glucose meter |
US6983177B2 (en) * | 2003-01-06 | 2006-01-03 | Optiscan Biomedical Corporation | Layered spectroscopic sample element with microporous membrane |
US20040131088A1 (en) * | 2003-01-08 | 2004-07-08 | Adtran, Inc. | Shared T1/E1 signaling bit processor |
ATE510605T1 (en) | 2003-03-14 | 2011-06-15 | Univ Columbia | SYSTEMS AND METHODS FOR BLOOD BASED THERAPY USING A MEMBRANELESS MICROFLUID EXCHANGE DEVICE |
US20060076295A1 (en) | 2004-03-15 | 2006-04-13 | The Trustees Of Columbia University In The City Of New York | Systems and methods of blood-based therapies having a microfluidic membraneless exchange device |
EP1625386B8 (en) * | 2003-03-24 | 2021-07-28 | Intuity Medical, Inc. | Analyte concentration detection devices and methods |
AU2004231988B2 (en) * | 2003-04-16 | 2010-04-15 | Drexel University | Acoustic blood analyzer for assessing blood properties |
US7588733B2 (en) | 2003-12-04 | 2009-09-15 | Idexx Laboratories, Inc. | Retaining clip for reagent test slides |
KR100639776B1 (en) * | 2004-01-05 | 2006-10-27 | 바이오메드포토닉스 주식회사 | A method for the detection of lateral flow assay and strip and Laser-induced Epifluorescence and compact scanner therefor |
EP1711590B1 (en) | 2004-01-08 | 2016-12-14 | Dako Denmark A/S | Apparatus and methods for processing biological samples and a reservoir therefore |
TWI258586B (en) * | 2004-01-13 | 2006-07-21 | Neupro Technology Co Ltd | Immunochemical detection device |
US7422905B2 (en) * | 2004-02-27 | 2008-09-09 | Medtronic, Inc. | Blood coagulation test cartridge, system, and method |
US7439069B2 (en) * | 2004-02-27 | 2008-10-21 | Nippoldt Douglas D | Blood coagulation test cartridge, system, and method |
BRPI0418539A (en) * | 2004-03-05 | 2007-05-22 | Egomedical Swiss Ag | analyte test system for determining the concentration of an analyte in a physiological fluid |
US7399637B2 (en) * | 2004-04-19 | 2008-07-15 | Medtronic, Inc. | Blood coagulation test cartridge, system, and method |
WO2005103663A1 (en) * | 2004-04-23 | 2005-11-03 | Arkray, Inc. | Analyzer and method of manufacturing the same |
WO2005111580A1 (en) * | 2004-05-07 | 2005-11-24 | Optiscan Biomedical Corporation | Sample element with fringing-reduction capabilities |
US8323564B2 (en) * | 2004-05-14 | 2012-12-04 | Honeywell International Inc. | Portable sample analyzer system |
US20060001551A1 (en) * | 2004-06-30 | 2006-01-05 | Ulrich Kraft | Analyte monitoring system with wireless alarm |
US20060000710A1 (en) * | 2004-06-30 | 2006-01-05 | Klaus Peter Weidenhaupt | Fluid handling methods |
US20060000709A1 (en) * | 2004-06-30 | 2006-01-05 | Sebastian Bohm | Methods for modulation of flow in a flow pathway |
US20060002817A1 (en) * | 2004-06-30 | 2006-01-05 | Sebastian Bohm | Flow modulation devices |
US20060019406A1 (en) * | 2004-07-23 | 2006-01-26 | Ning Wei | Lateral flow device for the detection of large pathogens |
EA010662B1 (en) | 2004-08-13 | 2008-10-30 | Эгомедикаль Технологиз Аг | Analyte test system for determining the concentration of an analyte in a physiological or aqueous fluid |
ATE369562T1 (en) * | 2004-09-09 | 2007-08-15 | Analyticon Biotechnologies Ag | LATERAL FLOW MEASURING DEVICE AND MEASURING METHOD FOR ANALYTES |
US7550267B2 (en) * | 2004-09-23 | 2009-06-23 | University Of Washington | Microscale diffusion immunoassay utilizing multivalent reactants |
US20060068500A1 (en) * | 2004-09-28 | 2006-03-30 | Kimberly-Clark Worldwide, Inc. | Detecting yeast infections using a lateral flow assay |
US20060078471A1 (en) * | 2004-10-12 | 2006-04-13 | Witty Thomas R | Apparatus and method for a precision flow assay |
DE502004006789D1 (en) | 2004-11-25 | 2008-05-21 | Roche Diagnostics Gmbh | Device for analyzing samples |
AT502915B1 (en) * | 2004-12-23 | 2008-01-15 | Hoffmann La Roche | DEVICE FOR THERMOSTATIZING A MEASURING CELL IN AN ANALYZER AND MEASURING CELL, WHICH CAN BE REPLACED INTO AN ANALYZER REPLACEABLE |
US20070144976A1 (en) * | 2004-12-24 | 2007-06-28 | Matthias Franzreb | Micro-reactor |
US8936755B2 (en) | 2005-03-02 | 2015-01-20 | Optiscan Biomedical Corporation | Bodily fluid composition analyzer with disposable cassette |
US7722537B2 (en) * | 2005-02-14 | 2010-05-25 | Optiscan Biomedical Corp. | Method and apparatus for detection of multiple analytes |
US20060189925A1 (en) | 2005-02-14 | 2006-08-24 | Gable Jennifer H | Methods and apparatus for extracting and analyzing a component of a bodily fluid |
JP4586130B2 (en) * | 2005-02-22 | 2010-11-24 | 丸石化成株式会社 | Sample liquid collection device |
WO2006098804A2 (en) * | 2005-03-11 | 2006-09-21 | Chembio Diagnostic Systems, Inc. | Dual path immunoassay device |
US7189522B2 (en) * | 2005-03-11 | 2007-03-13 | Chembio Diagnostic Systems, Inc. | Dual path immunoassay device |
US20090111197A1 (en) * | 2005-03-29 | 2009-04-30 | Inverness Medical Switzerland Gmbh | Hybrid device |
US8206650B2 (en) * | 2005-04-12 | 2012-06-26 | Chromedx Inc. | Joint-diagnostic spectroscopic and biosensor meter |
US20100245803A1 (en) * | 2005-04-12 | 2010-09-30 | Chromedx Inc. | Blood sample holder for spectroscopic analysis |
CA2507323A1 (en) * | 2005-05-13 | 2006-11-13 | Chromedx Inc. | Diagnostic whole blood and plasma apparatus |
US7740804B2 (en) * | 2005-04-12 | 2010-06-22 | Chromedx Inc. | Spectroscopic sample holder |
CA2517299A1 (en) * | 2005-08-26 | 2007-02-26 | Chromedx Inc. | Hollow needle assembly |
ES2675044T3 (en) | 2005-06-03 | 2018-07-06 | Board Of Regents Of The University Of Texas System | Electrochemistry and electrogenerated chemiluminescence with a single faradaic electrode |
US20060281187A1 (en) | 2005-06-13 | 2006-12-14 | Rosedale Medical, Inc. | Analyte detection devices and methods with hematocrit/volume correction and feedback control |
US20080101991A1 (en) * | 2005-06-23 | 2008-05-01 | Arkray, Inc. | Analysis Tool |
CA2615278A1 (en) * | 2005-08-31 | 2007-03-08 | Egomedical Technologies Ag | Coagulation test system |
AU2005336057A1 (en) * | 2005-08-31 | 2007-03-08 | Egomedical Technologies Ag | Analyte test system using non-enzymatic analyte recognition elements |
US8382681B2 (en) | 2005-09-30 | 2013-02-26 | Intuity Medical, Inc. | Fully integrated wearable or handheld monitor |
US8801631B2 (en) | 2005-09-30 | 2014-08-12 | Intuity Medical, Inc. | Devices and methods for facilitating fluid transport |
US9561001B2 (en) | 2005-10-06 | 2017-02-07 | Optiscan Biomedical Corporation | Fluid handling cassette system for body fluid analyzer |
US8153444B2 (en) * | 2005-10-13 | 2012-04-10 | Auric Enterprises, Llc | Immuno gold lateral flow assay |
US7344893B2 (en) * | 2005-10-13 | 2008-03-18 | Auric Enterprises, Llc | Immuno-gold lateral flow assay |
US8075852B2 (en) * | 2005-11-02 | 2011-12-13 | Affymetrix, Inc. | System and method for bubble removal |
US7763453B2 (en) | 2005-11-30 | 2010-07-27 | Micronics, Inc. | Microfluidic mixing and analytic apparatus |
US9056291B2 (en) | 2005-11-30 | 2015-06-16 | Micronics, Inc. | Microfluidic reactor system |
JP5028804B2 (en) * | 2006-01-19 | 2012-09-19 | ソニー株式会社 | Functional device |
GB2438669A (en) * | 2006-03-07 | 2007-12-05 | Inverness Medical Switzerland | Sensing apparatus having a pair of coils and an oscillating member |
US20070224643A1 (en) * | 2006-03-09 | 2007-09-27 | Mcpherson Paul H | Methods and compositions for the diagnosis of diseases of the aorta |
US20080261261A1 (en) * | 2006-03-31 | 2008-10-23 | Kmg2 Sensors Corporation | System/unit and method employing a plurality of magnetoelastic sensor elements for automatically quantifying parameters of whole blood and platelet-rich plasma |
US7837941B2 (en) * | 2006-04-07 | 2010-11-23 | Agamatrix, Inc. | Method and apparatus for monitoring alteration of flow characteristics in a liquid sample |
ATE542583T1 (en) | 2006-05-22 | 2012-02-15 | Univ Columbia | METHOD FOR MEMBRANE-LESS MICROFLUID EXCHANGE IN AN H-FILTER AND FILTERING OF THE EXTRACTION FLUID OUTPUT STREAMS |
GB0611701D0 (en) * | 2006-06-14 | 2006-07-26 | Biochrom Ltd | Analytical apparatus |
AU2007265628B2 (en) | 2006-06-23 | 2012-12-06 | Perkinelmer Health Sciences, Inc. | Methods and devices for microfluidic point-of-care immunoassays |
US20100233033A1 (en) * | 2006-06-26 | 2010-09-16 | Nippon Telegraph And Telephone Corporation | Flow cell and method for manufacturing the same |
DK2047253T3 (en) * | 2006-07-17 | 2016-02-15 | Universal Biosensors Pty Ltd | ELECTROCHEMICAL DETECTION OF MAGNETIC PARTICLE MOBILITY |
US20080101986A1 (en) * | 2006-10-31 | 2008-05-01 | Selwayan Saini | Analytical test strip with electroluminescent module |
US7384798B2 (en) * | 2006-10-31 | 2008-06-10 | Hewlett-Packard Development Company, L.P. | Method of detecting analytes in a microfluidic sample and a system for performing the same |
US20080101987A1 (en) * | 2006-10-31 | 2008-05-01 | Selwayan Saini | Analytical test strip with electroluminescent lamp |
EP2092339B1 (en) * | 2006-12-12 | 2012-05-16 | Koninklijke Philips Electronics N.V. | Microelectronic sensor device for detecting label particles |
WO2008071218A1 (en) * | 2006-12-14 | 2008-06-19 | Egomedical Swiss Ag | Monitoring device |
US7824879B2 (en) * | 2007-01-09 | 2010-11-02 | Cholestech Corporation | Device and method for measuring LDL-associated cholesterol |
WO2008092470A1 (en) * | 2007-01-29 | 2008-08-07 | Egomedical Swiss Ag | Resealeable container for storing moisture sensitive test elements |
WO2008137213A1 (en) * | 2007-05-02 | 2008-11-13 | Siemens Healthcare Diagnostics Inc. | Piezo dispensing of a diagnostic liquid onto a reagent surface |
CN101688875B (en) * | 2007-05-02 | 2014-07-23 | 西门子医疗保健诊断公司 | Method for measuring amount of analyte in bilfluid in microfluidic device |
US8597190B2 (en) | 2007-05-18 | 2013-12-03 | Optiscan Biomedical Corporation | Monitoring systems and methods with fast initialization |
WO2009029561A2 (en) * | 2007-08-24 | 2009-03-05 | Advanced Liquid Logic, Inc. | Bead manipulations on a droplet actuator |
US8529472B2 (en) * | 2007-09-04 | 2013-09-10 | Panasonic Corporation | Blood analysis device and blood analysis system using the same |
US8449833B2 (en) * | 2007-10-29 | 2013-05-28 | Koninklijke Philips Electronics N.V. | Frustrated total internal reflection biosensor cartridge |
KR100886914B1 (en) * | 2007-11-01 | 2009-03-09 | 주식회사 아이센스 | Cartridge for chemical measurement of blood and apparatus using the same |
EP2208046B1 (en) * | 2007-11-05 | 2019-12-11 | Koninklijke Philips N.V. | Method for detecting redispersion of beads |
WO2009068583A2 (en) * | 2007-11-26 | 2009-06-04 | Atonomics A/S | Separation and detection device with means for optimization of the capillary drag force |
JP2011514182A (en) | 2008-02-04 | 2011-05-06 | ザ トラスティーズ オブ コロンビア ユニバーシティ イン ザ シティ オブ ニューヨーク | Fluid separation apparatus, system, and method |
EP2260300B1 (en) * | 2008-03-07 | 2013-09-25 | Advanced Microdevices Pvt Ltd | Method and device for particle removal and droplet preparation for qualitative and quantitative bioanalysis |
SE533103C2 (en) * | 2008-04-01 | 2010-06-29 | Tommy Forsell | Blood Viscosity Analysis |
CA2725264C (en) | 2008-05-30 | 2017-06-20 | Intuity Medical, Inc. | Body fluid sampling device -- sampling site interface |
EP2299904B1 (en) | 2008-06-06 | 2019-09-11 | Intuity Medical, Inc. | Medical measurement method |
US9636051B2 (en) | 2008-06-06 | 2017-05-02 | Intuity Medical, Inc. | Detection meter and mode of operation |
US20100022916A1 (en) | 2008-07-24 | 2010-01-28 | Javanbakhsh Esfandiari | Method and Apparatus for Collecting and Preparing Biological Samples for Testing |
WO2010070521A1 (en) | 2008-12-18 | 2010-06-24 | Koninklijke Philips Electronics N.V. | Sensing device for sensing a fluid |
US8042748B2 (en) | 2008-12-19 | 2011-10-25 | Zodiac Pool Systems, Inc. | Surface disruptor for laminar jet fountain |
US8177141B2 (en) * | 2008-12-19 | 2012-05-15 | Zodiac Pool Systems, Inc. | Laminar deck jet |
US8448499B2 (en) | 2008-12-23 | 2013-05-28 | C A Casyso Ag | Cartridge device for a measuring system for measuring viscoelastic characteristics of a sample liquid, a corresponding measuring system, and a corresponding method |
US9658222B2 (en) | 2009-03-02 | 2017-05-23 | Mbio Diagnostics, Inc. | Planar waveguide based cartridges and associated methods for detecting target analyte |
US9212995B2 (en) | 2009-03-02 | 2015-12-15 | Mbio Diagnostics, Inc. | System and method for detecting multiple molecules in one assay |
US8300993B2 (en) * | 2009-03-02 | 2012-10-30 | Mbio Diagnostics, Inc. | Waveguide with integrated lens |
US8331751B2 (en) | 2009-03-02 | 2012-12-11 | mBio Diagnositcs, Inc. | Planar optical waveguide with core of low-index-of-refraction interrogation medium |
EP3357568A1 (en) | 2009-04-14 | 2018-08-08 | Biocartis NV | Hifu induced cavitation with reduced power threshold |
AU2010237532B2 (en) | 2009-04-15 | 2014-11-20 | Biocartis Nv | Optical detection system for monitoring rtPCR reaction |
JP5758877B2 (en) | 2009-04-15 | 2015-08-05 | ビオカルティ ナームローゼ フェノーツハップBiocartis NV | Bioanalytical sample chamber protection |
JP5766180B2 (en) | 2009-05-06 | 2015-08-19 | ビオカルティ ナームローゼ フェノーツハップBiocartis NV | Device for cutting a sample carrier |
AU2010257118B2 (en) | 2009-06-04 | 2014-08-28 | Lockheed Martin Corporation | Multiple-sample microfluidic chip for DNA analysis |
US9554742B2 (en) | 2009-07-20 | 2017-01-31 | Optiscan Biomedical Corporation | Fluid analysis system |
WO2011011462A1 (en) | 2009-07-20 | 2011-01-27 | Optiscan Biomedical Corporation | Adjustable connector and dead space reduction |
CN102482071B (en) * | 2009-07-20 | 2015-07-29 | 莫纳什大学 | Three-dimensional microfluidic systems |
WO2011049044A1 (en) * | 2009-10-19 | 2011-04-28 | 国立大学法人東京工業大学 | Biosensor using magnetic microparticles |
US10746752B2 (en) | 2009-11-13 | 2020-08-18 | Ventana Medical Systems, Inc. | Opposables and automated specimen processing systems with opposables |
US9498791B2 (en) | 2009-11-13 | 2016-11-22 | Ventana Medical Systems, Inc. | Opposables and automated specimen processing systems with opposables |
KR101358549B1 (en) | 2009-11-13 | 2014-02-05 | 벤타나 메디컬 시스템즈, 인코포레이티드 | Thin film processing apparatuses for adjustable volume accommodation |
WO2011065981A1 (en) | 2009-11-30 | 2011-06-03 | Intuity Medical, Inc. | Calibration material delivery devices and methods |
US10876964B2 (en) * | 2009-12-18 | 2020-12-29 | Koninklijke Philips N.V. | System, apparatus and method for determining a substance within a fluid |
KR101851117B1 (en) | 2010-01-29 | 2018-04-23 | 마이크로닉스 인코포레이티드. | Sample-to-answer microfluidic cartridge |
WO2011127436A2 (en) | 2010-04-08 | 2011-10-13 | Hemosonics, Llc | Hemostatic parameter display |
EP3156796A1 (en) | 2010-06-09 | 2017-04-19 | Optiscan Biomedical Corporation | Measuring analytes in a fluid sample drawn from a patient |
US10330667B2 (en) | 2010-06-25 | 2019-06-25 | Intuity Medical, Inc. | Analyte monitoring methods and systems |
WO2012001127A1 (en) | 2010-06-30 | 2012-01-05 | Csem Centre Suisse D'electronique Et De Microtechnique Sa Recherche Et Developpement | Pipette tip, pipette system and method for performing analysis with the pipette tip and system |
WO2012019109A1 (en) * | 2010-08-05 | 2012-02-09 | Abbott Point Of Care Inc. | Oscillating immunoassay method and device |
WO2012019104A1 (en) | 2010-08-05 | 2012-02-09 | Abbott Point Of Care Inc. | Immunoassay method and device with magnetically susceptible bead capture |
US9233370B2 (en) | 2010-08-05 | 2016-01-12 | Abbott Point Of Care Inc. | Magnetic immunosensor and method of use |
WO2012019108A1 (en) | 2010-08-05 | 2012-02-09 | Abbott Point Of Care Inc. | Magnetic immunosensor with trench configuration and method of use |
GB201014316D0 (en) | 2010-08-27 | 2010-10-13 | Univ Dublin City | A agglutination assay method and device |
WO2012037369A1 (en) | 2010-09-15 | 2012-03-22 | Mbio Diagnostics, Inc. | System and method for detecting multiple molecules in one assay |
MX2013004184A (en) | 2010-10-15 | 2013-07-29 | Lockheed Corp | Micro fluidic optic design. |
US9522396B2 (en) | 2010-12-29 | 2016-12-20 | S.D. Sight Diagnostics Ltd. | Apparatus and method for automatic detection of pathogens |
US8603835B2 (en) * | 2011-02-10 | 2013-12-10 | Chembio Diagnostic Systems, Inc. | Reduced step dual path immunoassay device and method |
AU2012364908B2 (en) | 2011-02-15 | 2017-08-03 | Hemosonics, Llc | Devices, systems and methods for evaluation of hemostasis |
JP6019485B2 (en) * | 2011-03-24 | 2016-11-02 | ベーリンガー インゲルハイム マイクロパーツ ゲゼルシャフト ミット ベシュレンクテル ハフツングBoehringer Ingelheim microParts GmbH | Blood filtration instrument and method |
WO2012159021A2 (en) | 2011-05-19 | 2012-11-22 | Hemosonics, Llc | Portable hemostasis analyzer |
EP2729784A4 (en) | 2011-07-06 | 2015-05-13 | Optiscan Biomedical Corp | Sample cell for fluid analysis system |
JP6223337B2 (en) | 2011-08-03 | 2017-11-08 | インテュイティ メディカル インコーポレイテッド | Body fluid extraction measuring instrument |
EP2802417B1 (en) | 2012-01-09 | 2019-05-15 | Micronics, Inc. | Microfluidic reactor system |
US9588113B2 (en) | 2012-02-22 | 2017-03-07 | Church & Dwight Co., Inc. | Methods for electronic analyte assaying |
US9322054B2 (en) | 2012-02-22 | 2016-04-26 | Lockheed Martin Corporation | Microfluidic cartridge |
US9952149B2 (en) | 2012-11-30 | 2018-04-24 | The University Of North Carolina At Chapel Hill | Methods, systems, and computer readable media for determining physical properties of a specimen in a portable point of care diagnostic device |
WO2014100725A1 (en) | 2012-12-21 | 2014-06-26 | Micronics, Inc. | Portable fluorescence detection system and microassay cartridge |
WO2014100743A2 (en) | 2012-12-21 | 2014-06-26 | Micronics, Inc. | Low elasticity films for microfluidic use |
EP2935908B1 (en) | 2012-12-21 | 2019-08-14 | PerkinElmer Health Sciences, Inc. | Fluidic circuits and related manufacturing methods |
USD728120S1 (en) | 2013-03-15 | 2015-04-28 | Ventana Medical Systems, Inc. | Arcuate member for moving liquids along a microscope slide |
WO2014182847A1 (en) | 2013-05-07 | 2014-11-13 | Micronics, Inc. | Device for preparation and analysis of nucleic acids |
CA2911303C (en) | 2013-05-07 | 2021-02-16 | Micronics, Inc. | Methods for preparation of nucleic acid-containing samples using clay minerals and alkaline solutions |
WO2014182844A1 (en) | 2013-05-07 | 2014-11-13 | Micronics, Inc. | Microfluidic devices and methods for performing serum separation and blood cross-matching |
EP2999988A4 (en) | 2013-05-23 | 2017-01-11 | S.D. Sight Diagnostics Ltd. | Method and system for imaging a cell sample |
WO2014205412A1 (en) | 2013-06-21 | 2014-12-24 | Intuity Medical, Inc. | Analyte monitoring system with audible feedback |
IL227276A0 (en) | 2013-07-01 | 2014-03-06 | Parasight Ltd | A method and system for preparing a monolayer of cells, particularly suitable for diagnosis |
US10082500B2 (en) | 2013-08-22 | 2018-09-25 | Franz Baudenbacher | Device and method for detecting a target analyte |
EP3039477B1 (en) | 2013-08-26 | 2021-10-20 | S.D. Sight Diagnostics Ltd. | Digital microscopy systems, methods and computer program products |
KR20150039051A (en) * | 2013-10-01 | 2015-04-09 | 삼성전자주식회사 | Blood filter device separating plasma or serum from blood and the use thereof |
WO2015095239A1 (en) | 2013-12-18 | 2015-06-25 | Optiscan Biomedical Corporation | Systems and methods for detecting leaks |
MX2016012881A (en) | 2014-04-02 | 2017-05-10 | Chembio Diagnostic Systems Inc | Immunoassay utilizing trapping conjugate. |
EP3594360B1 (en) | 2014-04-24 | 2021-06-23 | Lucira Health, Inc. | Colorimetric detection of nucleic acid amplification |
US10073091B2 (en) * | 2014-08-08 | 2018-09-11 | Ortho-Clinical Diagnostics, Inc. | Lateral flow assay device |
WO2016030897A1 (en) | 2014-08-27 | 2016-03-03 | S.D. Sight Diagnostics Ltd | System and method for calculating focus variation for a digital microscope |
US10175225B2 (en) | 2014-09-29 | 2019-01-08 | C A Casyso Ag | Blood testing system and method |
US20160116466A1 (en) | 2014-10-27 | 2016-04-28 | Chembio Diagnostic Systems, Inc. | Rapid Screening Assay for Qualitative Detection of Multiple Febrile Illnesses |
CN108474934B (en) | 2015-09-17 | 2022-01-18 | 思迪赛特诊断有限公司 | Method and apparatus for detecting entities in a body sample |
CN105628747B (en) * | 2015-12-18 | 2019-03-22 | 上海奥普生物医药有限公司 | Clotting time device for testing and analyzing and its method for testing and analyzing |
CA3015368A1 (en) | 2016-03-14 | 2017-09-21 | Diassess Inc. | Systems and methods for performing biological assays |
CA3015377A1 (en) * | 2016-03-14 | 2017-09-21 | Diassess Inc. | Devices and methods for modifying optical properties |
AU2017232342B2 (en) | 2016-03-14 | 2022-04-21 | Pfizer Inc. | Devices and methods for biological assay sample preparation and delivery |
WO2017160840A1 (en) | 2016-03-14 | 2017-09-21 | Diassess Inc. | Selectively vented biological assay devices and associated methods |
CA3018536A1 (en) | 2016-03-30 | 2017-10-05 | S.D. Sight Diagnostics Ltd | Distinguishing between blood sample components |
US11099175B2 (en) | 2016-05-11 | 2021-08-24 | S.D. Sight Diagnostics Ltd. | Performing optical measurements on a sample |
EP4177593A1 (en) | 2016-05-11 | 2023-05-10 | S.D. Sight Diagnostics Ltd. | Sample carrier for optical measurements |
KR101865055B1 (en) * | 2016-09-02 | 2018-06-08 | (주)지엠에스바이오 | Glucose measuring strip |
US10172401B1 (en) * | 2016-12-17 | 2019-01-08 | Simple Texan Llc | Backing plate for magnetic attachment |
JP6941939B2 (en) * | 2016-12-22 | 2021-09-29 | リンテック株式会社 | Inspection member and manufacturing method of inspection member |
US11080848B2 (en) | 2017-04-06 | 2021-08-03 | Lucira Health, Inc. | Image-based disease diagnostics using a mobile device |
EP3612838A2 (en) | 2017-04-20 | 2020-02-26 | Hemosonics, LLC | Disposable system for analysis of hemostatic function |
US10549275B2 (en) | 2017-09-14 | 2020-02-04 | Lucira Health, Inc. | Multiplexed biological assay device with electronic readout |
GB2569344A (en) * | 2017-12-14 | 2019-06-19 | Randox Laboratories Ltd | Fluidic card assembly |
USD910200S1 (en) | 2018-12-21 | 2021-02-09 | Lucira Health, Inc. | Test tube |
CN211905402U (en) * | 2019-11-22 | 2020-11-10 | 京东方科技集团股份有限公司 | Detection chip and detection system |
CN110681297B (en) * | 2019-11-25 | 2023-05-30 | 徐州蓝湖信息科技有限公司 | Chemical reagent preparation diffusion accelerator |
WO2021195120A1 (en) * | 2020-03-24 | 2021-09-30 | In Diagnostics, Inc. | Clinical spectrophotometer for general chemistry, immuno-assay and nucleic acid detection |
USD953561S1 (en) | 2020-05-05 | 2022-05-31 | Lucira Health, Inc. | Diagnostic device with LED display |
USD962470S1 (en) | 2020-06-03 | 2022-08-30 | Lucira Health, Inc. | Assay device with LCD display |
GB2622895A (en) * | 2022-12-23 | 2024-04-03 | Flexotronix Ltd | Housing |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3233975A (en) * | 1962-03-05 | 1966-02-08 | Ames Lab Tek Inc | Prothrombin reaction chamber |
US3650698A (en) * | 1969-12-04 | 1972-03-21 | Technicon Corp | Apparatus for the automatic determination of the coagulation, aggregation and or flocculation, or the like, rates of fluids, and novel reaction intensifying agent for use therewith |
US4088448A (en) * | 1975-09-29 | 1978-05-09 | Lilja Jan Evert | Apparatus for sampling, mixing the sample with a reagent and making particularly optical analyses |
US4323536A (en) * | 1980-02-06 | 1982-04-06 | Eastman Kodak Company | Multi-analyte test device |
US4678757A (en) * | 1985-04-11 | 1987-07-07 | Smithkline Diagnostics, Inc. | Device and method for whole blood separation and analysis |
US4756884A (en) * | 1985-08-05 | 1988-07-12 | Biotrack, Inc. | Capillary flow device |
US4761381A (en) * | 1985-09-18 | 1988-08-02 | Miles Inc. | Volume metering capillary gap device for applying a liquid sample onto a reactive surface |
US4780280A (en) * | 1985-06-29 | 1988-10-25 | Boehringer Mannheim Gmbh | Test carrier |
US4849340A (en) * | 1987-04-03 | 1989-07-18 | Cardiovascular Diagnostics, Inc. | Reaction system element and method for performing prothrombin time assay |
Family Cites Families (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US27866A (en) * | 1860-04-10 | Improved mode of securing metal hoops on cotton-bales | ||
US2616796A (en) * | 1950-11-25 | 1952-11-04 | Fred J Schilling | Apparatus for determining a coagulation factor of blood samples |
GB1088421A (en) * | 1964-01-07 | 1967-10-25 | Harshaw Chemicals Ltd | A method and apparatus for depositing a coating on the internal walls of capillary or smallbore tubes |
US3395210A (en) * | 1964-02-07 | 1968-07-30 | Warner Lambert Pharmaceutical | Lyophilized diagnostic reagent for the determination of blood coagulation factors |
DE1617732C2 (en) * | 1966-03-01 | 1972-12-21 | Promoveo-Sobioda & Cie, Seyssinet (Frankreich) | Device for examining living cells of microorganisms |
US3450501A (en) * | 1966-03-28 | 1969-06-17 | Bruce J Oberhardt | Prothrombin time determination |
US3520659A (en) * | 1967-10-20 | 1970-07-14 | Xerox Corp | Method and apparatus for use in determining prothrombin time of a blood sample |
US3635678A (en) * | 1969-06-13 | 1972-01-18 | Baxter Laboratories Inc | Clot-timing system and method |
US3695842A (en) * | 1970-03-12 | 1972-10-03 | Intern Technidyne Corp | Method and system for analyzing a liquid |
US3691017A (en) * | 1970-05-06 | 1972-09-12 | Worthington Bio Chem Corp | Means and method for chemical analysis |
US3672351A (en) * | 1970-08-17 | 1972-06-27 | Richard W Ubersax | Disposable blood test device |
BE792113A (en) * | 1971-12-13 | 1973-05-30 | Technicon Instr | MIXER FOR LIQUIDS CONTAINING MAGNETIC PARTICLES |
US3861197A (en) * | 1973-06-29 | 1975-01-21 | Technicon Instr | Method and apparatus for determining the viscosity of a liquid sample |
US3880714A (en) * | 1973-07-18 | 1975-04-29 | Warner Lambert Co | Diagnostic reagent |
SE380100B (en) * | 1974-02-07 | 1975-10-27 | Monega Anstalt | |
US3918908A (en) * | 1974-05-17 | 1975-11-11 | Geomet | Method for prothrombin testing |
US4097237A (en) * | 1977-03-04 | 1978-06-27 | Technicon Instruments Corporation | Determination of cells in blood |
US4176973A (en) * | 1977-07-29 | 1979-12-04 | Gregory Stephen A | Stenotype tape marking attachment |
JPS5469497A (en) * | 1977-11-12 | 1979-06-04 | Kyoto Daiichi Kagaku Kk | Method and device for measuring blood solidification time |
US4344438A (en) * | 1978-08-02 | 1982-08-17 | The United States Of America As Represented By The Department Of Health, Education And Welfare | Optical sensor of plasma constituents |
US4233029A (en) * | 1978-10-25 | 1980-11-11 | Eastman Kodak Company | Liquid transport device and method |
US4310399A (en) * | 1979-07-23 | 1982-01-12 | Eastman Kodak Company | Liquid transport device containing means for delaying capillary flow |
US4302313A (en) * | 1979-07-23 | 1981-11-24 | Eastman Kodak Company | Electrode-containing device with capillary transport between electrodes |
US4321057A (en) * | 1979-09-20 | 1982-03-23 | Buckles Richard G | Method for quantitative analysis using optical fibers |
US4413407A (en) * | 1980-03-10 | 1983-11-08 | Eastman Kodak Company | Method for forming an electrode-containing device with capillary transport between electrodes |
DE3029579C2 (en) * | 1980-08-05 | 1985-12-12 | Boehringer Mannheim Gmbh, 6800 Mannheim | Method and means for separating plasma or serum from whole blood |
US4366241A (en) * | 1980-08-07 | 1982-12-28 | Syva Company | Concentrating zone method in heterogeneous immunoassays |
US4426451A (en) * | 1981-01-28 | 1984-01-17 | Eastman Kodak Company | Multi-zoned reaction vessel having pressure-actuatable control means between zones |
US4391905A (en) * | 1981-02-12 | 1983-07-05 | Miles Laboratories, Inc. | System for the determination of glucose in fluids |
US4391906A (en) * | 1981-02-12 | 1983-07-05 | Miles Laboratories, Inc. | System for the determination of glucose in fluids |
US4340669A (en) * | 1981-02-12 | 1982-07-20 | Miles Laboratories, Inc. | System for the determination of glucose in fluids |
US4473457A (en) * | 1982-03-29 | 1984-09-25 | Eastman Kodak Company | Liquid transport device providing diversion of capillary flow into a non-vented second zone |
DE3233809A1 (en) * | 1982-09-11 | 1984-03-15 | Boehringer Mannheim Gmbh, 6800 Mannheim | CUEVETTE FOR DETERMINING CHEMICAL COMPOUNDS IN LIQUIDS |
DE3247608A1 (en) * | 1982-12-23 | 1984-07-05 | Boehringer Mannheim Gmbh, 6800 Mannheim | TEST STRIP |
US4558014A (en) * | 1983-06-13 | 1985-12-10 | Myron J. Block | Assay apparatus and methods |
IT1196349B (en) * | 1983-12-02 | 1988-11-16 | Vertrik Bioteknik Ab | DEVICE FOR CHEMICAL ANALYSIS AND USE OF IT |
US4654127A (en) * | 1984-04-11 | 1987-03-31 | Sentech Medical Corporation | Self-calibrating single-use sensing device for clinical chemistry and method of use |
ATE143289T1 (en) * | 1984-06-13 | 1996-10-15 | Applied Research Systems | APPARATUS USED IN CHEMICAL TESTING PROCEDURES |
US4596695A (en) * | 1984-09-10 | 1986-06-24 | Cottingham Hugh V | Agglutinographic reaction chamber |
US4826759A (en) * | 1984-10-04 | 1989-05-02 | Bio-Metric Systems, Inc. | Field assay for ligands |
FR2580407B1 (en) * | 1985-04-11 | 1987-06-26 | Vieillard Didier | METHOD AND APPARATUS FOR MEASURING COAGULATION OF BLOOD PLASMA |
DE3523969A1 (en) * | 1985-07-04 | 1987-01-08 | Boehringer Mannheim Gmbh | Coagulation-neutral, hydrophilic glass fibers |
US4963498A (en) * | 1985-08-05 | 1990-10-16 | Biotrack | Capillary flow device |
US4682895A (en) * | 1985-08-06 | 1987-07-28 | Texas A&M University | Fiber optic probe for quantification of colorimetric reactions |
US4712460A (en) * | 1985-11-18 | 1987-12-15 | Biotrack, Inc. | Integrated drug dosage form and metering system |
DE3616496A1 (en) * | 1986-05-16 | 1987-11-19 | Boehringer Mannheim Gmbh | ANALYZING ELEMENT FOR DETERMINING COAGLING PARAMETERS |
US4731330A (en) * | 1986-07-01 | 1988-03-15 | Biotrack, Inc. | Whole blood control sample |
US4753776A (en) * | 1986-10-29 | 1988-06-28 | Biotrack, Inc. | Blood separation device comprising a filter and a capillary flow pathway exiting the filter |
US4789629A (en) * | 1986-11-24 | 1988-12-06 | Smithkline Beckman Corporation | Method and device for collecting and testing for fecal occult blood |
US4912034A (en) * | 1987-09-21 | 1990-03-27 | Biogenex Laboratories | Immunoassay test device and method |
US4999163A (en) * | 1987-10-29 | 1991-03-12 | Hygeia Sciences, Inc. | Disposable, pre-packaged device for conducting immunoassay procedures |
US4818677A (en) * | 1987-12-03 | 1989-04-04 | Monoclonal Antibodies, Inc. | Membrane assay using focused sample application |
-
1987
- 1987-04-03 US US07/033,817 patent/US4849340A/en not_active Expired - Lifetime
-
1988
- 1988-03-31 CA CA000563129A patent/CA1310566C/en not_active Expired - Lifetime
- 1988-04-01 JP JP63503255A patent/JP2736091B2/en not_active Expired - Fee Related
- 1988-04-01 DE DE3853457T patent/DE3853457T2/en not_active Expired - Fee Related
- 1988-04-01 WO PCT/US1988/000980 patent/WO1988007666A1/en active IP Right Grant
- 1988-04-01 EP EP88903642A patent/EP0308494B1/en not_active Expired - Lifetime
- 1988-04-01 AU AU15918/88A patent/AU613623B2/en not_active Ceased
- 1988-04-01 AT AT88903642T patent/ATE120543T1/en not_active IP Right Cessation
-
1994
- 1994-05-23 US US08/247,411 patent/US5658723A/en not_active Expired - Lifetime
-
1997
- 1997-03-18 US US08/819,341 patent/US6197494B1/en not_active Expired - Fee Related
-
2002
- 2002-03-06 US US10/091,296 patent/US20020119486A1/en not_active Abandoned
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3233975A (en) * | 1962-03-05 | 1966-02-08 | Ames Lab Tek Inc | Prothrombin reaction chamber |
US3650698A (en) * | 1969-12-04 | 1972-03-21 | Technicon Corp | Apparatus for the automatic determination of the coagulation, aggregation and or flocculation, or the like, rates of fluids, and novel reaction intensifying agent for use therewith |
US4088448A (en) * | 1975-09-29 | 1978-05-09 | Lilja Jan Evert | Apparatus for sampling, mixing the sample with a reagent and making particularly optical analyses |
US4323536A (en) * | 1980-02-06 | 1982-04-06 | Eastman Kodak Company | Multi-analyte test device |
US4678757A (en) * | 1985-04-11 | 1987-07-07 | Smithkline Diagnostics, Inc. | Device and method for whole blood separation and analysis |
US4780280A (en) * | 1985-06-29 | 1988-10-25 | Boehringer Mannheim Gmbh | Test carrier |
US4756884A (en) * | 1985-08-05 | 1988-07-12 | Biotrack, Inc. | Capillary flow device |
US4761381A (en) * | 1985-09-18 | 1988-08-02 | Miles Inc. | Volume metering capillary gap device for applying a liquid sample onto a reactive surface |
US4849340A (en) * | 1987-04-03 | 1989-07-18 | Cardiovascular Diagnostics, Inc. | Reaction system element and method for performing prothrombin time assay |
US5658723A (en) * | 1987-04-03 | 1997-08-19 | Cardiovascular Diagnostics, Inc. | Immunoassay system using forced convection currents |
US6197494B1 (en) * | 1987-04-03 | 2001-03-06 | Cardiovascular Diagnostics, Inc. | Apparatus for performing assays on liquid samples accurately, rapidly and simply |
Cited By (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7053783B2 (en) | 2002-12-18 | 2006-05-30 | Biovigilant Systems, Inc. | Pathogen detector system and method |
US7437913B2 (en) * | 2003-06-06 | 2008-10-21 | Inverness Medical Switzerland Gmbh | Method and device for analysing a liquid |
US20050015000A1 (en) * | 2003-06-06 | 2005-01-20 | Nasr-Eddine Djennati | Method and device for analysing a liquid |
EP1666136A1 (en) * | 2003-07-24 | 2006-06-07 | AOGAKI, Ryoichi | Microreactor including magnetic barrier |
EP1666136A4 (en) * | 2003-07-24 | 2006-09-06 | Ryoichi Aogaki | Microreactor including magnetic barrier |
US7527741B2 (en) | 2003-07-24 | 2009-05-05 | Ryoichi Aogaki | Microreactor including magnetic barrier |
US20070013910A1 (en) * | 2004-07-30 | 2007-01-18 | Jian-Ping Jiang | Pathogen and particle detector system and method |
US8218144B2 (en) | 2004-07-30 | 2012-07-10 | Azbil BioVigilant, Inc. | Pathogen and particle detector system and method |
US7430046B2 (en) | 2004-07-30 | 2008-09-30 | Biovigilant Systems, Inc. | Pathogen and particle detector system and method |
US20060134387A1 (en) * | 2004-12-20 | 2006-06-22 | William Gottermeier | Multilayer article formed by adhesive ablation |
US20100108910A1 (en) * | 2005-07-15 | 2010-05-06 | Michael Morrell | Pathogen and particle detector system and method |
US7738099B2 (en) | 2005-07-15 | 2010-06-15 | Biovigilant Systems, Inc. | Pathogen and particle detector system and method |
US7749775B2 (en) | 2006-10-03 | 2010-07-06 | Jonathan Scott Maher | Immunoassay test device and method of use |
US20080081341A1 (en) * | 2006-10-03 | 2008-04-03 | Jonathan Scott Maher | Immunoassay test device and method of use |
US20090242799A1 (en) * | 2007-12-03 | 2009-10-01 | Bolotin Charles E | Method for the detection of biologic particle contamination |
US8628976B2 (en) | 2007-12-03 | 2014-01-14 | Azbil BioVigilant, Inc. | Method for the detection of biologic particle contamination |
US20110149277A1 (en) * | 2008-08-21 | 2011-06-23 | Siemens Healthcare Diagnostics Inc. | Multi-Layer Slides for Analysis of Urine Sediments |
US8462332B2 (en) * | 2008-08-21 | 2013-06-11 | Siemens Healthcare Diagnostics, Inc. | Multi-layer slides for analysis of urine sediments |
WO2010022019A1 (en) * | 2008-08-21 | 2010-02-25 | Siemens Healthcare Diagnostics Inc. | Multi-layer slides for analysis of urine sediments |
CN102209891A (en) * | 2008-11-07 | 2011-10-05 | 霍夫曼-拉罗奇有限公司 | Test element for detecting an analyte in a sample |
US9329128B2 (en) | 2008-11-07 | 2016-05-03 | Roche Diabetes Care, Inc. | Test element for detecting an analyte in a sample |
WO2010052307A3 (en) * | 2008-11-07 | 2010-07-22 | Roche Diagnostics Gmbh | Test element for detecting an analyte in a sample |
US8574514B2 (en) | 2008-11-07 | 2013-11-05 | Roche Diagnostics Operations, Inc. | Test element for detecting an analyte in a sample |
WO2010122158A1 (en) * | 2009-04-23 | 2010-10-28 | Dublin City University | A lateral flow assay device for coagulation monitoring and method thereof |
US9347931B2 (en) | 2009-04-23 | 2016-05-24 | Dublin City University | Lateral flow assay device for coagulation monitoring and method thereof |
US20130114076A1 (en) * | 2010-07-09 | 2013-05-09 | Koninklijke Philips Electronics N.V. | Cartridge with large-scale manufacturing design |
CN102985804A (en) * | 2010-07-09 | 2013-03-20 | 皇家飞利浦电子股份有限公司 | Cartridge with large-scale manufacturing design |
WO2012045753A1 (en) * | 2010-10-07 | 2012-04-12 | Boehringer Ingelheim Microparts Gmbh | Microfluidic platform |
EP2726852B1 (en) * | 2011-06-30 | 2020-11-25 | Koninklijke Philips N.V. | Multiple examinations of a sample |
CN105074465A (en) * | 2013-02-22 | 2015-11-18 | 株式会社日立高新技术 | Biological analyzing device and biomolecule analyzing equipment |
WO2021216764A1 (en) * | 2020-04-24 | 2021-10-28 | Leavitt Medical, Inc. D/B/A Lumea | Focal plane spacers for microscope slides and related systems and methods |
Also Published As
Publication number | Publication date |
---|---|
US4849340A (en) | 1989-07-18 |
DE3853457T2 (en) | 1995-10-26 |
ATE120543T1 (en) | 1995-04-15 |
CA1310566C (en) | 1992-11-24 |
AU613623B2 (en) | 1991-08-08 |
WO1988007666A1 (en) | 1988-10-06 |
DE3853457D1 (en) | 1995-05-04 |
JP2736091B2 (en) | 1998-04-02 |
EP0308494B1 (en) | 1995-03-29 |
US6197494B1 (en) | 2001-03-06 |
EP0308494A1 (en) | 1989-03-29 |
JPH01502797A (en) | 1989-09-28 |
EP0308494A4 (en) | 1990-07-04 |
US5658723A (en) | 1997-08-19 |
AU1591888A (en) | 1988-11-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6197494B1 (en) | Apparatus for performing assays on liquid samples accurately, rapidly and simply | |
EP0418235B1 (en) | Coagulation assay systems which utilize paramagnetic particles | |
US6656430B2 (en) | Affinity binding-based system for detecting particulates in a fluid | |
US6277641B1 (en) | Methods for analyzing the presence and concentration of multiple analytes using a diffusion-based chemical sensor | |
US6261519B1 (en) | Medical diagnostic device with enough-sample indicator | |
US6297061B1 (en) | Simultaneous particle separation and chemical reaction | |
US7258837B2 (en) | Microfluidic device and surface decoration process for solid phase affinity binding assays | |
US20070122819A1 (en) | Analyte assay structure in microfluidic chip for quantitative analysis and method for using the same | |
JPH08507210A (en) | Disposable devices in diagnostic assays | |
WO1999064846A1 (en) | Analyzer | |
KR102058506B1 (en) | Mechanical washing and measuring device for performing analyses | |
Vinitha et al. | A new polymer lab-on-a-chip (LOC) based on a microfluidic capillary flow assay (MCFA) for detecting unbound cortisol in saliva | |
US10677809B2 (en) | Rotatable cartridge with multiple metering chambers | |
GB2423266A (en) | A structure and method for detecting an analyte in a microfluidic chip | |
Rocks et al. | Automatic analysers in clinical biochemistry | |
JP3895307B2 (en) | Quantitative method and quantitative chip for target substance | |
KR0135782B1 (en) | Rapid accurate and simple coagulation assay system which | |
IL92191A (en) | Coagulation assay using dry chemical reagents and paramagnetic particles |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |